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Abstract
The provision of blood to patients in need is an imperative faced by all coun-
tries. Red blood cells (RBCs) are perishable with a life of 42 days. Inventory
managers at hospitals need to know how many RBCs to order so that the prob-
ability of experiencing shortages or outdates is minimised. This is complicated
by demand for RBCs being doubly stochastic. Both the number of patients that
need RBCs and quantity of RBCs they will need are random. For centralised
blood banks not only are the orders they receive from hospitals apparently ran-
dom, the supply of blood is also random.
This thesis shows that, in addition to the previously mentioned sources of volatil-
ity, the structure of the supply chain induces further volatility. This occurs due
to the presence of delivery delays and negative feedback loops in two locations
within the supply chain. It is shown how this volatility can be addressed with
some simple structural changes. But simply removing system induced volatil-
ity does not imply that the supply chain is optimised. To address optimality
the problem is formulated as a Markov decision process (MDP). A solution to
this process uses Stochastic Dynamic Programming (SDP), but this results in
a combinatoric explosion making the computation of an exact solution within a
reasonable time impossible. Instead, Stochastic Average Approximation (SAA)
is used to derive an approximate solution. Repeated, sequential application of
this is an exercise in Discrete Time Stochastic Control. A working control solu-
tion is provided in python. This solution can be arranged so as to mimic the two
echelon supply chain found in blood inventories. It is general enough to apply to
any discrete perishable inventory system with random demand and/or supply.
The approach for blood inventories requires credible estimates of demand for
RBCs. It is shown, using hierarchical Bayesian modelling and Discrete Phase-
Type (DPH) distributions, that credible estimates of demand at hospitals of any
size can be derived from publicly available information. In particular a new
method for obtaining the parameters of a DPH distribution is formulated and
applied to estimating transfusion quantities from publicly available sources.
An application of the proposed solution is presented for RBC inventories at both
hospitals and at the blood bank. For the blood bank in particular it is shown how
this can be used to determine the quantity of donors needed to meet demand
within a desired probability of adequacy.
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The following notation is used throughout this thesis. Unless indicated otherwise the defi-
nitions given here will apply.
Random variables and random functions will be denoted by upper-case letters. These may
be subscripted to denote time:
• At - quantity of patients needing a transfusion at time t
• D (.) - a function giving the expected cost of blood outdates
• G - the sum of expected shortage and outdate costs
• Nt - the population at time t from which patients needing a transfusion are drawn
• Q (`) - a discrete time Markov chain
• S (.) - a function giving the expected cost of blood shortages
• Ti - the time at which patient i requires a transfusion
• Ui (`) - quantity of blood with remaining life i ordered at time `
• Vi (w) - the quantity of blood with remaining life i used to satisfy demand w
• W (`) - quantity of blood demanded at time `
• Xi (`) - quantity of blood with remaining life i in inventory at time `
Realisations of random variables and constants will be denoted by lower case letters.
Where relevant, some of these are shown with subscripts.
• at - quantity of patients needing a transfusion at time t
• bi,j - the cell in ith row and jth column of the matrix B
• c - total cost associated with a given order quantity.
• ca - normal rate at which donors make an appointment to give blood
• cd - donor centre capacity
• ch - unit holding cost
• co - order cost
• cs - unit selling price
• cu - unit cost of an inventory item
• fa,t - donors becoming available at time t after being in lockout
• fb,t - the quantity of RBCs supplied to the blood bank by donors at time t
• fd,t - the quantity of donations requested by the blood bank at time t
• fh,t - the quantity of RBCs supplied to the hospital by the blood bank at time t
• fo,t - the quantity of blood requested from the blood bank by the hospital at time t
• fp,t - donors making an appointment at time t
• fr,t - the quantity of RBCs transfused at time t
• g - the delay between a hospital (or blood bank) making an order for blood and delivery
of that order
• h - time to absorption on a Markov chain, the quantity of blood required by a given
patient
• k - the delay between a request for donation and the donation being made
• m - the number of hospitals, the length of an elementary series
• n - the number of phases in a discrete phase-type distribution, the shelf life of RBCs
• p - probability of starting in a specific state.
• qi - the ith state in a sample path
• ri - number of times a process commences in state q0 = i
• s - a sample path of states visited prior to reaching an absorbing state
• sa,t - available donors at time t
• sb,t - blood bank inventory at time t
• sbs,t - blood bank supply line inventory at time t
• sl,t - donors that are locked out of the system at time t after giving blood
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• sh,t - hospital inventory at time t
• shs,t - hospital supply line inventory at time t
• sp,t - donors with an appointment to give blood at time t
• u - an order quantity
• va - appointment rate multiplier
• vbc - desired number of days inventory on hand at the blood bank
• vbs - Blood bank inventory smoothing parameter used
• vhc - desired number of days inventory on hand at a hospital
• vhs - hospital inventory smoothing parameter used
• w - realised demand
• xi - the ith unique state in an elementary series
• yj,k - number of transitions from state j to state k
• z - elementary series in an Acyclic Discrete Phase-Type distribution.
Vectors are denoted by bold lower case letters:
• a` - a vector of patient quantities at time `.
• b - a vector of absorption probabilities.
• ei - a vector of zeros where the ith entry is 1
• p - an initial state vector.
• ui - a binary vector for elementary series i
Matrices and random vectors are denoted by bold upper case letters:
• A - a matrix used to age blood by one day.
• B - a sub-stochastic transition matrix
• P - a single step transition matrix
• U () - a vector order quantities at time `
• V () - a vector of blood used to satisfy demand at time `
• X (`) - a random vector blood of different ages in an inventory at time `
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• Y () - blood available for transfusion at time `
Probability density functions and distribution parameters will be represented by lower case
Greek letters:
• ↵ - parameter of the beta distribution
•   - parameter of the beta distribution
•  1 - cost associated with shortages
•  2 - cost associated with outdates
• ⌘ - autocorrelation statistic
• ✓ - the proportion of transfusions performed at a given hospital
•   - an eigenvalue of an ADPH
• µ - the mean of a distribution, transformed hyper-parameter
• ⌫ - cost of computing a parameter value
• ⇡ - a density function
• ⇢ - a transformed hyper-parameter
•   - the standard deviation of a distribution.
•   - probability density of absorption times.
•  - density of demand for blood
• ! - density function for the time at which patient requires a transfusion.
Cumulative density functions are represented by upper case Greek letters:
• ⌦ - cumulative density function for the time at which patient requires a transfusion.
•   - cumulative density of absorption times
•  - cumulative density of demand for blood
Other symbols are used for miscellaneous purposes.
• 1 - a vector of ones.
• ` - discrete time
• S - a state space vector
11
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Ensuring a robust and reliable supply of fresh blood is a healthcare imperative for all na-
tions. Accordingly, a sufficient population of donors must be available to meet the demands
for transfusion within a reasonable probability of adequacy. An adequate population of
donors ensures an adequate supply of blood which means that blood is available when
needed. Following World Health Organisation guidelines [95], in Australia, the act of do-
nation is voluntary and without monetary reward. Although it is possible to donate specific
blood components, blood is usually donated whole. However, it is rarely used whole. In-
stead, it is separated into several blood components, the most prevalent of these being
plasma, red blood cells (RBCs), and platelets. State and federal governments wholly fund
the supply of fresh blood, and there is no charge for its transfusion levied against patients
requiring it regardless of whether they are public or private patients.
The quantity of blood donated is responsive to requests for donation by the central blood
bank, but it is fundamentally stochastic. The quantity of donors that respond to a request
for blood is random as is the delay between a call for donations by the blood bank and
the donor making an appointment. Similarly, the demand for blood is doubly stochastic as
both the number of patients needing blood and the quantity of blood needed are separate
random variables.
Once collected whole blood is subject to testing before separation into discrete compo-
nents. However, blood components are perishable. Fresh plasma can be frozen for up
1
to one year, RBCs have a shelf life of 42 days and platelets can only be kept for five
days.
Before use blood products are cross-matched to a patients blood type. There are eight
ABO blood types, and while it is preferable to transfuse a patient with blood matched to
their own type, in an emergency, it is possible to use a compatible type. O-negative blood,
for example, may be given to any patient regardless of their blood type. However, an O-
negative patient can only receive O-negative blood. Compatibility between different blood
types is shown in Figure 1.1.
Figure 1.1: Compatibility of ABO types [10]
1.1 The Supply Chain for Fresh Blood
The supply of blood starts with donors. Since there is a risk of transmitting pathogens
from donors to patients during transfusion, screening is applied to donors, donated blood
is checked thoroughly, and each unit is tracked from donor to transfusion or outdate. In
response to a request for blood, donors will make an appointment at a convenient donor
centre or mobile donor centre. Despite having an appointment, a proportion of donors will
not turn up. Some may call beforehand to reschedule while others just do not attend. These
donors may or may not make another appointment. Donors that keep their appointment
will give a single unit of whole blood after which they may not donate again for 84 days.
Donor centres send the blood they have collected to the central blood bank. The blood
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bank, in turn, sends out blood to fulfil hospital orders. These orders deplete the inventory
held at the blood bank which triggers a request for additional donations from the donor
population. Similarly, hospitals use blood held in their inventories to transfuse patients.
These transfusions deplete the hospital inventory resulting in a request to the blood bank
for additional blood.
Figure 1.2 shows a schematic of the blood supply chain. The flow of blood is presented
with solid arrows while the flow of information is shown with dotted arrows. It can be seen
that the demand for transfusions moves blood through the supply chain. Blood used in
satisfying demand is ultimately replaced via an order to the blood bank which in turn drives
the call for blood to the donor population. It shall be seen in Chapter 3 that this supply chain
structure has balancing feedback loops with delays and that the combination of these has
consequences for the volatility of inventory, orders and the donor population.
Figure 1.2: The blood supply chain
Of course, some blood does not stay fresh enough to be transfused. Blood reaching its
expiry date will outdate and is subsequently discarded. Such outdates can occur at either
the blood bank or at hospitals. The entire process costs the state and federal governments
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over $1bn each year [72].
Examination of the supply chain leads to the first research question considered in this
thesis:
Q1: How does the supply line structure affect the level and volatility of orders, inven-
tory and the donor population?
1.1.1 Shortage
Shortages occur when a hospital cannot transfuse a patient with blood that has been cross-
matched. In these circumstances a hospital has two options: they could transfuse the pa-
tient with a compatible type or, if the patient is stable enough, they can place an emergency
order to the blood bank for that blood type. While it is not optimal to transfuse a patient with
a different blood type, it is also costly to make an emergency order to the blood bank.
Perhaps of more significant concern is the situation where the blood bank is unable to fulfil
a hospital’s order, either in part or in full. Such situations can put patient well-being at
risk.
Lastly, and perhaps counter-intuitively, is the situation which can be caused by a substantial
increase in the donation quantities from both new and repeat donors. Such an increase can
occur in response to a disaster. For example, in the aftermath of the Victorian bushfires
in 2009 which saw 173 people killed an upwelling of public altruism saw unprecedented
donations of blood. These came from the repeat donor population as well as from new
donors. However, since donors are prevented from donating again for 84 days after giving
blood a much larger number of donors were in this lockout period. A consequence of
these unprecedented donation levels was that inventory levels fell and a shortage of blood
followed [27].
1.1.2 Wastage
Given the cost of supplying blood, waste management is clearly important. During 2011-
12, 63,413 units of blood products worth $23,040,286 were recorded as being disposed
[72]. One of the strategies implemented to address this is the reduction of inventory levels.
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However, a reduction in inventory levels also means that there is an increased chance of a
shortage. While transshipments between hospitals can address some of this shortage, if
not managed appropriately, it does constitute an increased risk to patient well-being.
In order to better understand the potential for shortages and outdates, it is essential that the
demand for blood be understood and that appropriate inventory levels are kept at hospitals
and the blood bank. The blood bank has the additional challenge of managing its donor
base to ensure a robust supply of fresh blood while maintaining enough available donors
to meet future supply. Consideration of these issues leads to the remaining research ques-
tions:
Q2: How should the distribution of demand for blood transfusions be mod-
elled?
Q3: What quantity of blood should be ordered to minimise the likelihood of shortages
and outdates?
Q4: How many donors are needed to ensure demand can be met?
1.2 Structure of Thesis
This thesis examines the current state of inventory management at hospitals and the blood
bank in Chapter 2. In Chapter 3 the structure of the blood supply chain is considered as
a source of inventory volatility and an approach is suggested to reduce it. A consequence
of this is that any approach addressing inventory levels in the blood supply chain should
also address system induced volatility. In Chapter 4 the demand for blood is considered. A
mathematical model which addresses transfusion quantities in a way consistent with WHO
transfusion guidelines is suggested. Chapter 5 uses stochastic control to derive optimal
ordering quantities for hospitals and the blood bank. The mathematical framework of the
approach is discussed, and results are presented. The final Chapter presents concluding





Ford W Harris undertook early work on the science of inventory management in his seminal
paper in 1913[52]. In this paper, the economic order quantity (EOQ) was derived for the
first time. His solution allowed manufacturers to derive how much of an item to order under
a simple set of assumptions. The derivation of this formula is fairly straightforward. The
total cost, c, associated with a given order quantity, u, can be expressed as the sum of
three subordinate costs. Let the unit cost of an inventory item be cu. Then the value of the
order is given by wcu where w is a fixed demand rate for the item. The ordering cost per
order is given by cowu where the cost of making the order is co. This is because
w
u orders
per year are expected. Finally, the cost of holding the inventory is given by chu2 since the
amount in the inventory will, on average, be halfway between u and 0 where ch is the unit
holding cost. Therefore the total cost, c, is given by:







To find the minimum of the total cost c, differentiate Equation (2.1) with respect to u and
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This gives the formal derivation of the EOQ. It is also worth noting that this quantity does
not depend on cu since this is unaffected by the order quantity. The reader may notice that
this formulation also gives the optimal order frequency m = wu⇤ where in this instance u
⇤
is the EOQ as defined in Equation (2.2). Figure 2.1 allows visualisation of the EOQ at the
point where the total cost is minimised.
Co
st
Number of Items Ordered
Order Cost Holding Cost Total Cost EOQ
Figure 2.1: The relationship between cost and order quantity. The EOQ is the point at
which the total order cost is minimised.
Now if Equation (2.2) is substituted into Equation (2.1) the minimum cost is given by:
c⇤ =
p
2cochw + wcu . (2.3)
Wilson [93] undertook a detailed analysis of the EOQ as proposed by Harris. In the absence
of modern computers, he developed a simple approach to calculating this quantity so that
stockroom managers could quickly work out the EOQ under a variety of situations. He also
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points out circumstances which might require holding more stock and those which might
require holding less.
Under the EOQ model, cost has been shown to be quite inelastic to changes in order


























where c⇤ is the cost associated with the EOQ and u⇤ is the EOQ. If one were to assume that
the quantity ordered was, say, 20% more than the EOQ (i.e., the ratio u/u⇤ is 1.2) solving
Equation 2.4 reveals that the cost only goes up by 1.67%. Similarly, if the order were, say,
10% lower than the EOQ (i.e., the ratio u/u⇤ is 0.9) the cost would only go up by 0.55%.









































Ratio of actual order quantity u to the EOQ u*
Figure 2.2: Cost is somewhat robust to changes in the order quantity.
Despite the robustness of this formula, there are some weaknesses. For example, while
Wilson [93] does mention the stochastic nature of demand, he does not take it into account
in his use of the EOQ.
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2.2 Stochastic Demand
IIt is easy to verify from observation that the demand for many products is not fixed but
is, instead, random. However, it is possible that an inventory manager might know the
distribution of demand in advance. Arrow et al. [5] make this assumption in their seminal
1951 paper. The paper addresses the inventory problem in three ways. First, the simple
situation where demand is known is considered, and a more rigorous derivation of the EOQ
is presented. Then, for the first time, stochastic demand is considered initially as a static
model, and later as a dynamic model.
This paper gives the first derivation of the (S, s) order policy. Under this policy, S is the
maximum stock to hold, and s is the reorder point. If the quantity on hand, x, is higher than
s then do not place an order. If x is less than s, then place an order of size S   x. The
challenge addressed is the derivation of S and s when demand is a random variable with
a known distribution function. They suggest that this distribution function can be estimated
from history but recognise that it may not be time invariant.
Further, they restrict themselves to the (S, s) class of policies and prove the optimality of
their solution only within that set. It was not until 1960 that the optimality of the (S, s)
policy over all possible ordering policies was proved by Scarf [86]. This policy is optimal
in minimising costs where the product has stochastic demand with an infinite lifetime, a
guaranteed supply, and linear holding and shortage costs.
Knowing the distribution of demand upfront may not be possible. It is more likely that an
estimate of the mean and variance of demand is able to be estimated from examination
of past demand without attributing it to any specific distribution. In this case it can can be
shown that there is an optimal single period ordering policy which maximises profit [85]. If
µw is the mean demand and  w is the standard deviation of demand then the optimal order
































cu is the unit item cost and cs is the unit selling price.
This approach can be modified so that it minimises costs instead of maximising profit. For
details, the reader is directed to Scarf [85].
2.2.1 Perishable Inventory
When a product is perishable, it encourages inventory managers to make smaller but more
frequent orders. It also encourages lower inventory levels [70]. In turn, this suggests a
modification to the (S, s) inventory policy would have relatively smaller values of S and
relatively larger values of s to allow for perishability of stock. A product lifetime of a single
period is identical to the single-period newsvendor problem. The (S, s) policy is no longer
optimal for product lifetimes which exceed this. The incentive to place larger orders is
greater if the distribution of product age favours items approaching expiry [43].
A common modification to the (S, s) policy requires that a replacement is ordered for each
item demanded. This modification is known as the (S   1, S) policy. To date, no analytical
solution has been provided to determine the optimal value of S however the process has
been used in several numerical studies, and the stationary distribution of the process has
been derived [79, 87].
The policy used to issue a perishable product also affects inventory volatility [61]. These
typically fall between two canonical extremes. When the oldest stock is used to meet de-
mand, the policy applied is known as first-in-first-out or FIFO policy. Conversely, when the
freshest stock is used first, the policy is known as last-in-first-out or LIFO policy. Use of a
LIFO policy increases the chance that older items will expire before they are used.
2.2.2 Blood Inventories
The first examination of blood inventories was carried out by Millard in 1959 [68]. His
thesis considered four possible models of blood banking for whole blood. In the first of
these models, Millard considered random demand for whole blood and random supply from
donors. The assumption made is that these are independent random variables. There was
no attempt to solve for an optimum inventory policy; rather the intent was to “provide insight
into the workings of random processes.” It is clear from an examination of these results that
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random supply encourages higher stock levels to offset the risk that requested blood might
not be forthcoming within the required horizon.
A reasonable portion of Millard’s thesis is devoted to what he calls the criterion problem.
That is: what are the appropriate performance measures for a blood inventory? After con-
sideration of several possibilities, he settles on the incidence of outdates and shortages.
Interestingly the ethical dimension of using cost as a performance measure is also dis-
cussed. Using cost to determine performance is a thorny issue when lives can be put at
risk from potential shortages arising from the optimisation.
This study also recognised the challenges that perishability presents for blood inventories.
Millard suggests keeping a buffer stock to guard against shortages and to treat this as a
control variable.
Last, Millard also discusses lead time in the supply of fresh blood. This is the first time lead
time is discussed in the literature and is an early recognition that delays play an essential
role in achieving a robust supply of fresh blood. Consideration of lead times is the motivation
behind research question Q1 while the complexity these add to the supply chain motivates
research question Q3.
2.2.3 Estimation of Demand
Since Millard’s 1959 thesis, various assumptions have been made as to the distributional
forms taken by supply and demand for whole blood and products derived from whole blood.
These are summarised in Table 2.1.
The most straightforward idea used is to fix demand before use in modelling. This ap-
proach was used by Pierskalla and Roach to model a hospital blood bank where demand is
known a priori [80]. This is akin to fixing individual patient transfusions to known quantities.
This approach may not be reasonable since patient transfusion quantities do vary. A re-
lated idea is to use empirical densities to model the demand for blood. This was exploited
by Jennings who analysed inventory control policies for a hospital blood bank. Only B+
blood was considered, and daily aggregate quantities demanded by physicians were col-
lected [56]. The actual transfusion quantities are not captured, so patient level attribution
is problematic. Rabinowitz also investigated hospital blood bank policies and, as he was


















































Millard 1959 [68] S,D
Elston and Pickrel 1963 [36] D* S,D D*
Jennings 1968 [56] S,D
Elston 1970 [37] S,D
Pierskalla and Roach 1972 [80] S,D
Rabinowitz 1973 [84] S,D
Graves 1982 [48] D
Kaspi and Perry 1983 [58] S,D
Prastacos 1984 [82] D
Kaspi and Perry 1984 [59] D S
Keilson and Seidmann 1990 [61] S,D
Goh et al 1993a [46] S,D
Goh et al 1993b [45] S,D
Olsson 2010 [76] D
Atkinson et al 2012 [7] S,D
Blake 2013 [18] S,D
Blake 2014 [17] S D
Abouee-Mehrizi 2014 [4] S,D
Abbasi and Seidmann 2014 [2] S,D
Table 2.1: Assumptions for the distribution of demand and supply of blood and derived
products made by various authors. S indicates supply and D indicates demand. The use of
‘*’ denotes that a given distribution has been used in supporting the rationale for the use of
an alternative distribution.
of two patients, specifically considers empirical patient level demand [84]. Unfortunately,
he does not provide these quantities in his paper. The use of empirical densities will cap-
ture actual variation in transfusion rates. However, without attributing these to a particular
distribution, it limits the ability to extend the results beyond what has been observed.
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In a general sense, the literature on modelling the blood supply chain is a subset of the
study of perishable inventory systems. In [61] for example, a Poisson process is used
for demand where each demand request is for a single unit. In the literature on blood
inventories, this has also been seen in [4] where the allocation of inventoried blood to
patients is examined.
Many distributional assumptions have been used to model the demand for blood. Some
of the earliest work in this area assumed that the quantity of demanded blood is Poisson
distributed [68]. This assumption did not distinguish between the quantities required by
different patients, nor did it distinguish between the different ABO types; instead demand
was considered in aggregate. While the Poisson distribution has some enticing analytical
properties, it does not require much consideration to conclude that actual demand is not
distributed this way. Nonetheless, use of the Poisson distribution in various guises to model
aggregate demand or to model a patient’s demand for blood is relatively ubiquitous. In [18]
for example, hospital orders are assumed to be Poisson, and Poisson demand is also used
in [1]. Since the sum of independent Poisson random variables is also a Poisson random
variable, it is implicit that patient demand is also Poisson. In [76] a similar idea is presented
in the more general case of perishable inventory.
It is important to recognise that the demand for blood is doubly stochastic. There is vari-
ation in both the number of patients requiring transfusion and the quantity each patient
is transfused. This was recognised in [36, 37] where the authors use a Poisson distribu-
tion to model patients arrivals and a logarithmic distribution to model the quantity of blood
required by each patient. They ultimately argue that the random variable derived from Pois-
son compounding of logarithmically distributed random variables has a negative binomial
distribution. Mathematically, this claim is correct and is also used in [34]. A related idea
is described in [46, 45] where a batch Poisson process is considered. Batch requests for
blood are Poisson distributed with a geometrically distributed batch size. However, the
monotonically decreasing density of the logarithmic or geometric distribution is restrictive
and does not reflect actual transfusion quantities.
To remove the dependence on Poisson processes, in [7] a renewal process is used for
transfusions. It is shown that a coefficient of variation (CV) of 1.32 is needed in order to
approach the significant day-to-day variation seen in transfusions. The authors report an
average transfusion rate of 51.82 units per day. If transfusions were a Poisson random
variable, then a CV of approximately 0.139 would be expected. Requiring an empirically
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derived CV of 1.32 is the final nail in the coffin for the use of a Poisson distribution to model
transfusions.
It should be noted that much of the literature on the demand for blood relates to modelling
of a hospital blood bank or similar. There is not much available on the quantity of blood
transfused. Nonetheless, it is possible to draw some conclusions regarding the distribution
of blood transfused from these papers by induction. There are a few papers in the medical
literature that explicitly consider transfusion quantities. In [29] blood transfusion rates in
acute trauma patients are presented in the context of patient mortality and the treatment
of massively transfused patients. A more extensive study is presented in [13] where it is
shown that the post-operative infection rates of patients undergoing cardiovascular surgery
increases with each unit of blood transfused. In both of these cases, there is no attempt to
characterise the distribution.
It is clear from the available literature that there is a strong dependence on the Poisson
distribution to model the quantity of blood transfused either in total or per patient with a few,
but notable, deviations. In one case a derivation from first principles seems to have been
attempted [36], but there has been no rigorous attempt to characterise the distribution of
blood transfusion quantities. The doubly stochastic nature of demand for blood motivates
research question Q2.
2.3 Current Practice
2.3.1 At the Hospital
The National Blood Authority (NBA) provides guidelines for hospital management of blood
inventories in Australia. Under these guidelines, each hospital is responsible for determin-
ing their specific inventory levels so that daily demand can be met but not so high that it
results in excess wastage. One measure recommended is that hospitals set a “day’s cover”
quantity (also known as the issuable stock index) to set appropriate inventory levels. This
quantity is determined a priori by inventory managers but can be estimated a posteriori by
dividing the inventory on hand by the average daily usage. The guidelines also encourage
the use of a FIFO issuing policy [71].
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Actual hospital practice is hard to find in the literature. However, there is one recent study
by Stanger et al. [88] that examines practice at seven UK hospitals. Of these hospitals,
none of them used complex mathematical models to set inventory levels. Instead, these
levels are set using experience with small adjustments up or down to achieve the desired
level. Reorder policies are similarly simple with some hospitals using a repeat, fixed order
quantity from the central blood bank, with the opportunity to place a second, adjustment
order later during the day. Other hospitals have a “use-one-and-order-one” policy which is
reflective of the (S 1, S) inventory policy. All hospitals surveyed by Stanger et al. enforced
a FIFO policy for issuing blood.
2.3.2 At the blood bank
At the blood bank the situation is a little more complicated. In addition to fulfilment of
hospital orders the blood bank must manage its own inventory and ensure that there are
enough available donors to meet future demand. To that end the International Society of
Blood Transfusion (ISBT) blood supply management (BSM) working group has established
five steps to blood supply management. The first two of these steps involve the assess-
ment of past RBC usage by hospitals and the preparation of annual supply forecasts. The
Australian Red Cross Blood Service (ARCBS) established a sales and operations planning
framework in 2010 to address these two steps. Under this framework, forecasts are pre-
pared over a 36 month forward horizon. These forecasts and the assumptions that underlie
them are reviewed monthly. These are translated into a supply plan which is then divided
into monthly collection targets for each state and territory [26].
In addition to these forecasts the ARCBS also has an inventory response team (IRT) to
manage the donor population so that the right donors are making appointments at the
right time. This team works on a short time horizon of one to six weeks. This team can
correct any perceived imbalances by, amongst other things, managing the number of donor
appointments booked in the future. With this in place the use of national appeals for blood
are a last resort strategy. The ARCBS acknowledge that there is more work to be done
to improve the time lag between the decision to take corrective action and the observed
improvement in inventory levels [27].
At the blood bank, the situation is a little more complicated. In addition to fulfilment of
hospital orders, the blood bank must manage its own inventory and ensure that there are
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enough available donors to meet future demand. To that end, the International Society of
Blood Transfusion (ISBT) blood supply management (BSM) working group has established
five steps to blood supply management. The first two of these steps involve the assess-
ment of past RBC usage by hospitals and the preparation of annual supply forecasts. The
Australian Red Cross Blood Service (ARCBS) established a sales and operations planning
framework in 2010 to address these two steps. Under this framework, forecasts are pre-
pared over a 36 month forward horizon. These forecasts and the assumptions that underlie
them are reviewed monthly. These are translated into a supply plan which is then divided
into monthly collection targets for each state and territory [26].
In addition to these forecasts, the ARCBS also has an inventory response team (IRT) to
manage the donor population so that the right donors are making appointments at the
right time. This team works on a short time horizon of one to six weeks. This team can
correct any perceived imbalances by, amongst other things, managing the number of donor
appointments booked in the future. With this in place, the use of national appeals for blood
is the last resort strategy. The ARCBS acknowledge that there is more work to be done
to improve the time lag between the decision to take corrective action and the observed
improvement in inventory levels [27].
Since the number of available donors ultimately restricts the supply of fresh blood, it begs
the question as to how many active donors are needed to ensure that supply is robust. This




The objective of this chapter is to present the case that the blood supply chain contains
previously unaccounted for variation, that arises as a consequence of the logistics and
structure of the system itself. A simple model of the blood supply chain is built using system
dynamics to demonstrate that instability can arise without recourse to stochastic demand
and supply. System dynamics is a subset of systems theory that examines the dynamic,
complex and non-linear behaviours of a system. The model is not calibrated to a real blood
inventory system. Since such systems include stochastic supply and demand, it would be
much harder to claim that the structure of the system itself is a source of volatility. The
model, therefore, has constant demand and supply and remains in equilibrium until a small
perturbation is applied to the level of transfusions. This small change causes instability and
oscillations in the model which can only be attributed to the design of the system itself. This
is a feature typical of complex systems. Readers wishing to become more familiar with the
principles of system dynamics are directed to Forrester [40, 41] and Sterman [89].
The literature review presented in Chapter 2 is extended in Section 3.1 with additional
literature relevant to this chapter. In Section 3.2 a description of the model is provided, and
the behaviour of each component is explained before the behaviour of the whole model is
demonstrated. Section 3.3 deals with the results of running the model. It demonstrates how
the system can generate volatility without the requirement for stochastic input. In Section




Two particular cases in the literature illustrate the difference between empirical volatility and
that captured in models used to simulate blood inventories. Atkinson et al. [7] present a
model based on a renewal process with a mean transfusion rate of 51.82 units per day.
On the face of it, this does not seem unreasonable. It is of note that in order to tune this
model to observed variation the authors require a coefficient of variation (CV) of 1.32 to
be applied to both supply and demand for blood. The magnitude of this CV is a critical
observation since a Poisson process would have to have an extremely low rate parameter
of 0.574 units per day to achieve an equivalent CV. Alternatively, with a mean transfusion
rate of 51.82 units per day, a Poisson process would have a standard deviation of 7.20
units, and therefore the CV would be 0.139, a long way from the 1.32 used by Atkinson et.
al.
The second case comes from a 2014 study by Blake and Hardy [17]. These authors build a
model of the Canadian blood bank. Their model captures the mean behaviour of the system
using a Poisson process for supply and a zero-inflated Poisson process for demand. They
consider two sites, and, in both cases, the empirical volatility of the blood inventory exceeds
that captured by their model.
Both of these cases suggest that volatility of blood may be influenced by other factor(s).
Note that the schematic of the blood supply chain in Figure 1.2 reveals the presence of two
feedback loops. The first of these exists between the hospital and the blood bank. Hospitals
maintain a desired level of inventory. However, transfusion of blood will deplete this, so the
shortfall is made up by requesting more blood from the blood bank. The second is between
the blood bank and the donor base. Like hospitals, the blood bank attempts to maintain
inventory at the desired level. However, fulfilment of hospital orders will deplete this, and
the shortfall is made up by requesting blood from donors.
It is known that inventories can exhibit instability as a result of delays due to the flow of
goods, and the flow of information and delays in feedback [40]. Statistical analysis of ag-
gregate system performance probably cannot be used to derive the non-linear behaviour
exhibited by such systems [41], and this may be why other researchers have not success-
fully captured volatility in blood inventories. Similarly, it may be why there has been no
consensus as to the appropriate distributions for supply and demand. These distributions
are not independent but inexorably bound up in the behaviour of the system.
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There are two types of feedback loops that can be present in system dynamics. The first of
these is a positive feedback loop, also known as a reinforcing loop. These feedback loops
reinforce existing behaviour in a system. For example, consider the interest earned on a
bank account. The accumulation of interest increases the account balance which in turn
yields yet more interest.
The second type of feedback present in system dynamics is the negative feedback loop.
These are also known as balancing loops. The presence of such loops causes goal-seeking
behaviour. A system with such feedback loops will seek a new state of balance. Con-
sider the act of standing. A person that is standing is in a balanced state. If pushed that
person will attempt to return to a balanced state very quickly or risk falling over. In the
presence of delays, however, such feedback loops can lead to oscillatory behaviour. Such
behaviour can be observed in thermostats which turn on heating when the temperature
is too low and provide cooling if the temperature is too high. Since thermostats do not re-
spond immediately to a change in temperature, oscillations around the desired temperature
will be observed. It is these negative feedback loops which are present in the blood supply
chain.
In order to understand the source of this instability, it is vital to understand both the delays
in the system and the feedback mechanisms. Blood inventories have negative feedback
loops in at least two locations. Negative feedback is present in the goal seeking behaviour
of hospitals’ inventory and in the inventory of the blood bank itself. The system also has
delays in the supply of blood by the blood bank to hospitals and in the donation of blood
by donors. The oscillatory behaviour we shall describe later can only occur because of
negative feedback and time delays. In fact, systems with negative feedback but without
time delays cannot oscillate [89]. Consideration of the structure and logistics of blood sup-
ply shows that it is not possible to remove delays. However, it is possible to make some
structural changes to the logistics of the blood supply chain to explicitly recognise the delay
and thereby ameliorate instability.
While the literature deals with easily identified determinants of inventory volatility, it is be-
lieved that this is the first time that the logistics of the blood supply chain itself are consid-
ered as a source of variability in blood inventories. In order to demonstrate this, a simple,
system dynamics model of blood inventory is created. This model considers the behaviour
of RBCs, a component of whole blood. Again, only the dynamic behaviour of the system
is of interest. There is no attempt to calibrate the models to actual data regarding the level
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and volatility in supply and demand. This point is elaborated on further in Section 3.2.5.
This model can create instability in RBC inventories without attributing it to the stochastic
nature of demand and supply and without assuming that RBCs are perishable.
3.2 The Model
InsightMaker [42] was used to build a model of the blood distribution system for RBCs.
The model contains three main sub-models: a donation process, a blood bank inventory
and a hospital inventory. Each of these is described before aggregate system behaviour
is examined. The model is started in equilibrium to understand the effect of the system
structure better. After twenty simulated days, a small increase in demand is simulated, and
the impact on the system is considered.
3.2.1 The Donation Process
The diagram in Figure 3.1 shows the donation process isolated from the blood supply sys-
tem. Within this process donors can be in one of three mutually exclusive states: they could
be available for appointment, sa,t, they could have an appointment to donate, sp,t, or they
may be unavailable after having given blood, sl,t. The total quantity of donors is assumed
to be fixed. This assumption is consistent with the real world process where donor popula-
tions are reasonably static or may even be declining [53, 97]. Donors that are available may
make an appointment to give whole blood at any time. Without any exogenous perturba-
tions, donors will make appointments at a constant rate, ca. Deviations from this rate arise
as a consequence of requests from the blood bank to increase or decrease the rate of sup-
ply. Specifically, the Australian Red Cross Blood Service employs an inventory response
team (IRT) to increase or decrease the rate of donation by managing the number of donor
appointments booked into the future and by making outbound calls to donors [26].
The stock of donors that are available to give whole blood, sa,t is depleted by donors that
make appointments, fp,t and replenished by donors that become available after completing
a period in lockout fa,t. At time t this quantity is given by:
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Figure 3.1: The process of donation. Donor stocks are shown as rectangles. Arrows




(fa,⌧   fp,⌧ ) d⌧ + sa,t0 , (3.1)
where t0 denotes the starting time. The rate of donor appointment making will vary depend-
ing on the blood bank’s demand for whole blood. This demand is exogenous to the donation
process and is captured as a donation multiplier which is an input to the appointment rate
multiplier. Of course, donors cannot respond instantly to requests for additional donations.
There is a delay between the blood bank’s request for a change in the donation rate and the
actual change in the number of appointments made. The appointment rate multiplier va,t
incorporates a third order exponential delay to capture this. A third order exponential delay
provides a simple, smoothed approach to addressing the delay between the blood bank’s
request for additional donors and the response of donors to that request. This allows the
number of donors making an appointment fp,t to be defined as:
fp,t = cava,tsa,t . (3.2)
On making an appointment donors join the queue to make a donation. The number of these
donors that actually donate on a given day is limited by the capacity, cd, of the donor centre.
When the quantity of donors with an appointment, sp,t, is less than this capacity then all
those donors will give blood on that day. Otherwise, any remaining donors will donate on a





(fp,⌧  min(sp,⌧ , cd))d⌧ + sp,t0 . (3.3)
Once a donor has given whole blood they are not allowed to donate again for a fixed period




(min(sp,⌧ , cd)  fa,⌧ )d⌧ + sl,t0 . (3.4)
The behaviour of this sub-model is now considered. The parameter values used are shown
in Table 3.1. Some of these values were chosen such that the system commences in
equilibrium. Starting the system in equilibrium is important as the transient effects of initial
values should not obscure the response of the system to the small shock that is applied
later. The recovery rate is chosen as 1/84 because once a donor has given blood, they
are unable to do so again for 84 days. So, on average 1/84 of the unavailable donors
will become available on each simulation day. The donor response delay captures the
delay between a call for additional donations and a change in the appointment making
behaviour of donors. Typically this would range between a few days and a few weeks
and is initially set at seven days. Sensitivity to this assumption is tested in Section 3.3.
The donor centre capacity was chosen so that it was greater than the average number of
donations. Donations are initially made at 75 % of this capacity, although in Section 3.3 the
capacity of the donor centres is increased to 10. With the values chosen and the structure
shown in Figure 3.1, this model remains in equilibrium with a constant supply of 6 units per
day provided that the capacity of the donor centre taking the blood from the donors is at 6
or greater. In order to match donations to demand the only action open to the blood bank
is to request an increase or decrease to the supply of whole blood. A multiplier to the rate
of donation is used to model these actions.
Figure 3.2 shows the consequences of increasing the demand for RBCs at day 20 by 50%
with a subsequent reversion of demand to earlier levels at day 50. The donor population
responds to the increase in demand by increasing donations for ten days. In this example,
the new rate of donation eventually exceeds the capacity of the donor centre which was
set at eight units per day and leads to a queue of donors building up in the system. Once
donors have made their donation, they are unavailable for a fixed period. It can be seen
in Figure 3.2 that the short-term increase in demand and the presence of limited capacity
within the donor centre causes a depletion of the stock of available donors. When demand
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Parameter Initial Value
Normal Appointment Rate 1/84
Recovery Rate 1/84
Donor Response Delay 7





Table 3.1: The initial values of parameters (InsightMaker calls these variables) and stocks
(in bold) used in the donation process model component. The only parameters that the
blood bank can change is the donation multiplier, shown in italics.
Figure 3.2: The top panel of the chart shows demand for blood increasing on day 20 and
returning to the original level on day 50. The remaining panels show how donations and
donor availability change in response.
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returns to previous levels, the quantity of blood donation is initially less than the previous
equilibrium levels, but it does re-converge to those levels after 100 days or so.
3.2.2 Blood Bank Inventory
The diagram in Figure 3.3 shows the structure of the blood bank inventory sub-model. This
inventory has a single stock which holds the RBCs. Let sb be the quantity of RBCs stored in
the blood bank inventory. This quantity is depleted by supplying RBCs to hospitals, fh, and
replenished by RBCs extracted from whole blood donations, fb. It is clear that, in addition
to defining the number of donors giving whole blood, Equation (3.2) also gives the number
of units collected since a single unit is taken from each donor.
Figure 3.3: A model of blood bank inventory.




(fb,⌧   fh,⌧ ) d⌧ + sb,t0 . (3.5)
Since it takes time to process orders from hospitals, fh,t incorporates a third order delay
of the actual hospital order fo,t. While there is a real sense of urgency to meet hospital
orders, they cannot be supplied instantly. There is a small delay, maybe a day or two,
between making an order and supply. This delay is caused by processing at the hospital
and at the blood bank and by transportation.
Hospitals order units of RBCs from the blood bank on a regular basis. It is usual for the
blood bank to smooth these orders using a simple rolling average process over some period
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This is used to define the inventory level, s⇤b,t the blood bank desires at time t by multiplying
by the number of days cover desired, vbc:
s⇤b,t = vbcf¯o,t . (3.7)
This derivation of the desired inventory level is consistent with practice at the blood bank
where continuous statistical analysis of blood issued to hospitals is used in demand fore-
casting [26]. The ratio of the actual inventory held by the blood bank and the desired
inventory defines an index sb,ts⇤b,t which in turn is used to increase or decrease the rate of
donation via a converter function shown in Figure 3.4. This is the donation multiplier dis-
cussed earlier. In this model, it is assumed that this is a simple function of the ratio of
actual inventory to desired inventory. If the ratio of actual RBCs held by the blood bank
to the desired inventory is less than one this converter function increases the demand for
whole blood. Conversely, if the ratio is greater than one the converter function decreases
the demand for whole blood. The philosophy behind this variable is to keep the level of
donations at a level that meets demand, thereby ensuring that there is an optimal buffer of
available donors should demand increase. This mechanism is a simplification of what hap-
pens at the blood bank when increases or decreases to the donation rate are required. Put
simply, when stock levels are below what is desired there is a mechanism which increases
the requests for donation and when stock levels are above what is desired the same mech-
anism will mitigate the need for too many donations. In reality, the blood bank uses the
IRT for this purpose. When the inventory levels are below those desired, the IRT will use
outbound calls to available donors to increase the rate of donation. When the inventory lev-
els are higher than those desired, the IRT can manage the future donation appointments.
Collection targets are broken down daily and by donor centre [26]. The use of a donation
multiplier is consistent with actions of the IRT.
As with the previous sub-model component the blood bank sub-model component is parametrised
so that it commences in equilibrium. These values are given in Table 3.2. On simulation
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Figure 3.4: The donation multiplier is a function of the ratio of the actual blood bank inven-
tory to the desired blood bank inventory.
day 20 a 5% increase in the level of hospital orders is applied. The only parameters the
blood bank can change are the number of days of stock on hand (Days Cover) and the
period over which hospital orders are smoothed (Smooth Period). The value of Days Cover
is based on the levels observed by the Australian Red Cross Blood Service and typically
ranges between four and ten days depending on the ABO type [27]. Eight days is chosen
as a reasonable value for this parameter. The Smooth Period is used to capture genuine
changes in the level of blood being ordered. Lower values of this parameter will make the
desired inventory level noisier. Higher values will delay changes in hospital orders being
included in the desired inventory level.
Parameter Initial Value




Normal Donation Quantity 6
Blood Bank Inv 48
Table 3.2: The initial values of parameters (InsightMaker calls these variables) and stocks
(in bold) used in the blood bank model component. Parameters shown in italics are those
that the blood bank can change.
The blood bank’s inventory level is more than adequate to cover the small increase in
demand from the hospital. There is an immediate requirement to increase donations as the
higher level of orders would otherwise cause the inventory to fall below the desired level.
The initial request for more donations overshoots because it is correcting for the difference
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Figure 3.5: The impact of a small increase in hospital orders on blood donations (blood in)
and supply to hospitals (blood out)
Figure 3.6: The impact of a small increase in hospital orders on the desired and actual
Blood Bank Inventory
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between orders and donations and the increased level of desired inventory. Figure 3.5
shows that the supply and demand for blood eventually converge approximately 30 days
after the change occurred.
It takes time for the full amount of the increase to be recognised in the blood bank’s desired
inventory level. It can be seen in Figure 3.6 that even though the quantity of RBCs in the
inventory increases it never achieves the desired inventory level. As soon as the level of
donations matches the level of demand, there is no mechanism to reduce the shortfall to
zero. In order to achieve a match, the target would have to be set at a quantity that is in
excess of the desired inventory.
3.2.3 Hospital Inventory
The structure of the hospital model is shown in Figure 3.7. It has a single stock, sh,t in
which RBCs are stored. This stock is depleted by transfusions, fr,t, and replenished by
deliveries of RBCs from the blood bank, fh,t.
Figure 3.7: The hospital inventory model




(fh,⌧   fr,⌧ )d⌧ + sh,t0 . (3.8)
A hospital will typically keep a few days supply of RBCs on hand to cover for unexpected
demand. Analogous to the blood bank model, and consistent with the NBA guidelines [71]
the average rate of transfusion, f¯r,t is used to determine the level of inventory the hospital
desires, s⇤h,t:
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s⇤h,t = vhcf¯r,t , (3.9)
where vhc is the number of days cover required by the hospital. Unlike the blood bank,
the hospital determines the gap between its actual inventory, sh,t, and its desired inventory,
s⇤h,t, in units of RBCs. The variation in the gap between actual and desired inventory is
smoothed with adjustment parameter vhs. The hospital will order fo,t units of RBCs from
the blood bank. This order is the average transfusion rate plus a portion of the inventory
gap.
fo,t = f¯r,t + vhs(s
⇤
h,t   sh,t) . (3.10)
Again this sub-model is parameterised so that it commences in equilibrium. These values
are shown in Table 3.3. The hospital can control some of these. A hospital may choose how
many days inventory to keep on hand (Hospital Cover) and how quickly to adjust discrepan-
cies in inventory (Hospital Inv Adj Period). Further, the hospital can smooth the transfusion
volumes over a number of days (Transfusion Smooth Period) to reduce volatility. The de-
sired number of days of RBCs on hand is chosen to offer a good chance of RBCs being
available while remaining low enough so that the likelihood of RBCs expiring is mitigated
[71]. It was decided to set this at eight days inventory on hand. Hospitals recognise that
smaller but regular orders are better at ensuring the freshness of supply [88]; therefore, the
inventory adjustment period is very low, and for the model is chosen to be one day.
Parameter Initial Value
Hospital Inv Adj Period 1
Hospital Cover 8
Transfusion smooth period 7
Normal Transfusion Rate 6
Hospital 48
Table 3.3: The initial values of parameters (InsightMaker calls these variables) and stocks
(in bold) for the hospital inventory component. Those in italics are parameters the hospital
can control.
When confronted with an increase in transfusions of just 5% the hospital inventory adjusts
quickly. The hospital initially orders more from the blood bank than required to cover the
increased transfusion rate as it also wishes to increase its inventory to cover a sustained
increase in demand. A spike in orders can be seen in Figure 3.8, however, this converges
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Figure 3.8: The impact of a small increase in transfusions on orders received
Figure 3.9: The impact of a small increase in transfusions on the hospital’s actual Inventory
and desired
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to a new level very quickly. The time taken for this convergence depends on the period over
which transfusions are smoothed and the inventory adjustment period.
In Figure 3.9 it can be seen that the hospital revises its desired inventory very quickly and
the actual inventory also converges to this level quickly.
3.2.4 The Complete Model
So far, each of the sub-models has been considered in isolation of one another. In order to
simulate the entire system, these sub-models need to be connected. The structure of the
complete model is shown in Figure 3.10. Each of the sub-models is shown surrounded by
a dashed box. At the top of the figure, the donation process described in Section 3.2.1 is
present. The donation process interacts with the blood bank inventory described in Section
3.2.2 and is shown in the middle of the figure. In turn, the blood bank inventory interacts
with the hospital inventory, described in Section 3.2.3. It is these interactions that manifest
the negative feedback loops described in Section 3.1. The negative feedback loops occur
through interfacing variables which describe the flow of information, or as flows of RBCs
between inventory stocks. It is these interfaces that give rise to the instabilities described in
Section 3.3. Since these are key to the behaviour of the complete model, these interfaces
between sub-models will now be described.
The first of these interfaces is the variable ”Donation Multiplier” described briefly in Sections
3.2.1 and 3.2.2. This variable represented the blood bank’s request for an increase or
reduction in the quantity of whole blood donated. It is a converter function which takes
values as shown in Figure 3.4.
The second interfacing quantity is the number of units of whole blood donated. Rather than
being a fixed quantity this is now variable and is a function of the number of donors with an
appointment to give blood and the capacity of the donor centre.
The variable ”Hospital Orders” is the next interfacing quantity to consider. In determining
the size of this order, the hospital has a process which smooths out volatility. Similarly,
on observing this quantity, the blood bank applies further smoothing before using it to de-
termine its desired inventory level. This interfacing variable controls flow from the hospital
to the blood bank. The fulfilment of hospital orders flows in the opposite direction. This
variable incorporates delays as a consequence of processing and transportation.
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Figure 3.10: The layout of the entire model
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3.2.5 Simplifications in the Model
It is worth noting that this model simplifies the supply chain in some aspects. While the real
world system is discrete in the number of donors, units of whole blood and units of RBCs,
this simple model has assumed they are continuous. It is not felt that this simplification has
a significant role to play in determining the overall behaviour of the system. The quantities
of donors and units of each blood product in the real world situation are much larger and
can be thought of as approaching a limit where discretisation ceases to be relevant.
Blood products are perishable. In particular RBCs have a shelf life of 42 days post donation.
In real inventory systems, this is an important consideration since it inevitably causes some
stock to be discarded and would need to be taken into account when determining stock
levels and order quantities. Including this into the model does not change the intrinsic
behaviour of the system, so it has been left out for clarity.
There is only a single donor centre in the model. The real system has fixed and mobile
donor centres distributed geographically. The model can be thought of as summing over
all donor centres in the real world system. Similarly, there is only one hospital which can
be thought of as the sum over all hospitals. This aggregation in the model ignores the
potential for hospitals to cooperate. It is known that there are benefits to pooling in reducing
shortages and outdates in RBC inventories [81, 83, 33, 55] but it is not clear from this
research whether centralisation reduces the volatility in the system or if it merely makes
the system more robust to the presence of volatility. Notwithstanding this, the inclusion of
additional hospitals and/or donor centres would only introduce a further set of delays in the
processing and transportation of blood products.
The behaviour of donors does not explicitly include the breaking of appointments. Appoint-
ment breaking is a significant feature of the actual donation processes [24, 69] and another
source of volatility. In the model, it is possible to think of this being captured by the capacity
of the donor centre. A greater quantity of appointment breaking behaviour is analogous to
a reduction in the capacity of the donor centre as an appointment is made and held open,
but no whole blood is given.
Only a single blood type is considered. It is reasonable to expect that the behaviour of
different blood types are isomorphic to each other. That is, what is true for one blood
type is also true of another. A possible exception to this is O-negative blood which can be
given to any patient in an emergency. This may cause demand for this blood type to be
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responsive to demand from other blood types as well as demand from O-negative patients.
The examination of this potential effect is not in the scope of this model.
Donations and transfusions are not stochastic in this model. In this sense, the model differs
substantially from the real blood supply chain. However, the objective of this research is
to demonstrate that the logistics and structure of the system itself can generate instability.
This would be made substantially more difficult to isolate in the presence of stochastic do-
nations and transfusions. The volatility of supply and demand would mask the underlying
behaviour of the system. In previous research the presence of system induced instabilities
has not been isolated; it is effectively ‘rolled-up’ into an aggregated view of volatility. In this
research, it is vital to isolate system induced instability from the volatility present in real sup-
ply and demand, so neither donations nor transfusions are allowed to be stochastic.
Lastly, the model is not calibrated to levels expected in actual blood supply chains. It
is assumed that when the system commences six units of RBCs per day are transfused
and, after a short period, this increases by a small amount after which the behaviour of
the system can be observed. Such an approach is typical within the system dynamics
literature [40, 41, 89]. The behaviour of the system is linear in the sense that application
of a scalar multiple to demand, initial stock levels and donor centre capacity will result
in system behaviour that is also a multiple of that scalar. Evidence of this is present in
data from the Australian Red Cross Blood Service where it is shown that a reduction in
days cover resulted in a concomitant decrease in the standard deviation of daily whole
blood packs received [27]. In this sense, the magnitude of the quantities flowing through
the system is not of concern. Instead, how they flow through the system and the system
behaviour they engender is of interest.
3.3 Results
Attention is now given to the aggregate behaviour of the model. Initial conditions for the
model are given in Table 3.4. With these conditions, the model remains in equilibrium. It is
assumed that on simulation day 20 there is a 5% increase in the level of transfusions.
With these conditions it can be seen in Figure 3.11 that the hospital can recognise the
change in transfusion quite quickly by increasing its desired inventory level. The actual
quantity of RBCs held begins to oscillate with a frequency of approximately seven days.
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Parameter Initial Value
Normal Appointment Rate 1/84
Recovery Rate 1/84
Donor Response Delay 7
Donor Centre Capacity 10
BB Cover 8
BB Delivery Delay 2
Hospital Inv Adj Period 1
Hospital Cover 8






Table 3.4: The initial values of model parameters (InsightMaker calls these variables) and
model stocks (in bold)
This oscillation occurs because the hospital does not take unfulfilled orders into account
when placing the next order. Each assessment of its inventory position does not consider
orders that it has made but not supplied at the time of placing the current order.
Since the orders placed by the hospital oscillate, it follows that the inventory stored at the
blood bank will also oscillate. In observing these oscillating orders, the blood bank has a
constantly changing view of its desired inventory level. The oscillation is amplified because
the blood bank wishes to store a fixed multiple of average orders on hand. The classic bull-
whip effect manifests in the blood bank’s desired inventory level. These fluctuations in the
desired inventory level, in turn, cause fluctuations in the request for donations. However,
the request donations take time to be realised. As a consequence, the blood bank inventory
becomes quite erratic but does eventually settle into a more regular oscillation.
The request for additional whole blood donations eventually results in more donors making
an appointment, but the capacity of the donor centre limits the number of appointments
the donor centre can process. Figure 3.12 shows that the increased level of donor ap-
pointments increases the number of unavailable donors as more of the available donors
make appointments and eventually donate. This decreases the number of available donors
thereby requiring a higher proportional rate of donation to maintain the quantity of blood
donated. This instability in the donor population does settle down, but it continues to expe-
rience some small oscillations.
Oscillatory behaviour in the units of RBCs that are used to fill hospital orders can also
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Figure 3.11: The impact of a small increase in the transfusion rate on the desired and actual
inventories at the hospital and at the blood bank.
Figure 3.12: The impact of a small increase in the transfusion rate on the donor population.
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Figure 3.13: The concomitant impact of a small increase in the transfusion rate on the
fulfilment of hospital orders and donations received
be seen. Again, this is because the order quantities themselves are oscillating. This is
shown in Figure 3.13 where the quantity of whole blood donated becomes quite erratic as
it responds to the changing requests of the blood bank within the capacity limitations of the
donor centre.
The example described in detail here is but one of many parametrisations of the model
which results in oscillatory behaviour. In order to demonstrate that it is not unique, several
other parametrisations are presented. Since the primary concern is removing volatility from
the inventory in the blood bank, only the impact of these parameter changes on the blood
bank inventory is presented.
Figure 3.14 shows the impact of changing the level of transfusions on the blood bank in-
ventory. Increasing the transfusions to patients initially causes greater instability in the
blood bank inventory but this does eventually settle down to a more stable oscillation. Inter-
estingly, decreasing the quantity of patients transfusions to 95% of their equilibrium levels
causes an increase in the quantity of RBCs in the blood bank inventory due to the increased
instability in the system.
If a change to the delay between when a hospital places an order and when that order is de-
livered is applied, the oscillatory behaviour continues as shown in Figure 3.15. Increasing
the delay causes this behaviour to stabilise more quickly than in the base case. This oscilla-
tion has a much higher amplitude than the base case. Peak to trough this is on the order of
40 units of blood. Similarly decreasing the delay does not eliminate the oscillations. While
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they no longer have erratic behaviour, the amplitude of the oscillations is greater again and
appears to increase with time. This starts with a peak to trough amplitude of about 30 units
and increases to an amplitude of about 55 units.
Lastly, the delay between the request for greater donations and those increased donations
making an appointment to donate whole blood is changed. Increasing this delay to 10
simulation days from 7 simulation days increases the amplitude of the instability to 100
units peak to trough. Decreasing the delay to 3 simulation days converges to a stable peak
to trough oscillation of around 25 units.
It is clear from this simple model that volatility in blood inventories is indeed part of the
structure of the blood supply chain. It does raise an interesting question though: what
changes could be made to the supply chain to mitigate such volatility?
Figure 3.14: Sensitivity of the blood bank inventory to changes in transfusion rate. The top
section is the base case. The middle section has an increase of a further 5% above the
base case and the bottom section has a decrease to 95% of the base case.
3.4 Strategies to Mitigate Volatility
In this section an approach for mitigating the volatility at hospitals and the blood bank with
some simple structural changes to the blood supply chain is considered.
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Figure 3.15: Sensitivity of the blood bank inventory to changes in the supply delay. The top
section is the base case. The middle section shows the result of increasing this delay to
three days and the bottom section shows the result of a decrease to 1 day.
Figure 3.16: Sensitivity of the blood bank inventory to changes in the donation delay. The
top section is the base case. The middle section shows the result of increasing the delay
from 7 days to 10 days and the lower section shows the result of decreasing the delay from
7 days to 3 days.
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3.4.1 At the Hospital
The first of these strategies requires adding another stock to the hospital component of
the model. This stock keeps track of the supply line of blood coming from the blood bank.
The addition of this stock to ameliorate instability is a common practice in system dynamics
[89], but it also is considered in aggregate with the inventory on hand in the literature on
the (S   1, S) policy for perishable products with a constant lead time [79]. This stock is
denoted as shs,t. The stock is depleted as supplies of RBCs, fh,t, arrive from the blood
bank and replenished when the hospital places an order, fo,t. At any time t the level of the




(fo,⌧   fh,⌧ )d⌧ + shs,t0 . (3.11)
The inclusion of this stock allows the hospital to manage its actual and desired stock levels
taking into account both the inventory it has on hand and RBCs that have been ordered
but not yet supplied. This requires the hospital to determine the desired level for this stock,
s⇤hs,t. The calculation of this level is:
s⇤hs,t = gf¯o,t . (3.12)
Here g is the delay between making an order and receiving that order. The hospital also
has to determine how it recovers the difference between the actual and desired levels of
both the inventory on hand and the unfulfilled orders in the supply line. It can do so by
choosing appropriate levels for adjustment factors vhl and vhs









This change would also require the blood bank to make sure that hospital orders are pro-
cessed in totality. Shortfalls should be made up in later shipments otherwise there will be a
portion of orders that would never be met.
When this change is applied, oscillations are removed from the hospital inventory and the
desired inventory at the blood bank as shown in Figure 3.17b. Contrast this with Figure
3.17a where these oscillations had an amplitude of about 20 units for the hospital inventory
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and about 100 units for the desired inventory in the blood bank. It is true that oscillations
remain in the actual blood bank inventory, but this arises entirely from the delays in the
donation process.
(a) Inventories - Original
(b) Inventories
Figure 3.17: These two panels show the impact on both the hospital and blood bank inven-
tories when applying the hospital correction strategy only. The top panel shows the result
before the correction and the bottom panel shows the result after the correction.
It is not surprising to see that oscillations persist in the donor population as shown in Figure
3.18b. Unlike what was observed in Figure 3.18a these oscillations are more regular rather
than the noisy fluctuations shown earlier.
Consistent with these observations it can be seen in Figure 3.19b that the oscillations have
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(a) Donor population - Original
(b) Donor Population
Figure 3.18: These two panels show the impact on the donor population when applying the
hospital correction strategy only. The top panel shows the result before the correction and
the bottom panel shows the result after the correction.
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(a) Orders and Donations - Original
(b) Orders and Donations
Figure 3.19: These two panels show the impact on donations received by the blood bank
and order fulfilment when applying the hospital correction strategy only. The top panel
shows the result before the correction and the bottom panel shows the result after the
correction.
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been completely removed from the fulfilment of orders to the hospital. Again this can be
contrasted with Figure 3.19a which shows a cycle in order fulfilment and noisy behaviour
in the quantity of donations. A cycle remains in the quantity donated; again this is entirely
due to delays in the donation process and the capacity of the donor centre.
3.4.2 At the Blood Bank
Like the situation with the hospital this strategy also requires a separate stock. This stock
keeps track of whole blood needed but not yet donated. Let this stock be sbs,t. This stock
is depleted as donations are made, fb,t, and replenished by the requests to donate whole




(fd,⌧   fb,⌧ ) d⌧ + sbs,t0 . (3.14)
The inclusion of this stock gives the blood bank the ability to manage the total quantity of
RBCs in the system by recognising both the quantity held in its inventory and the requests
for donation. The blood bank would need to determine an appropriate quantity to hold in
sbs,t. This is directly proportional to the delay between requesting a change in donation and
this change manifesting in the actual quantity of whole blood donated which is denoted as
k.
s⇤bs,t = kf¯d,t . (3.15)
The required quantity for donation, fd,t, can be determined as the average hospital or-
der quantity plus an adjustment to allow for the difference between desired and actual
inventory levels and the difference between desired and actual whole blood requested for
donation:









In order to apply these changes, it is necessary to make some adjustments to the donation
process as well. Instead of using an index to change the donation quantity, the required
increase is expressed in units of blood.
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These changes cause some amelioration of the volatility seen in the unmodified model. In
Figure 3.20b oscillations remain in the hospital inventory and the desired inventory level of
the blood bank. This is because changes to the hospital inventory structure have not been
applied in this case. Nonetheless, the oscillation in the blood bank inventory has been
reduced dramatically. Comparing this to Figure 3.20a demonstrates how the blood bank
inventory fluctuations have changed.
Figure 3.21b shows that the fluctuations in the state space of the donor population are again
much smaller than those seen in Figure 3.21a. The only source of the residual oscillation
comes from the fact that the correction to the hospital inventory model is absent.
Consistent with this theme, in Figure 3.22b it can be seen how the fulfilment of orders to
the hospital continues to show oscillations but the level of oscillation in blood donations has
again reduced dramatically. Peak to trough this is about 2.5 units. Compare this to Figure
3.22a where the peak to trough change is about 7.5 units and where the capacity of the
donor centre was reached.
3.4.3 Combining the Strategies
Applying both strategies in the model allows all of the various measures to converge to
stable solutions. Figure 3.23b shows that all of the inventory measures no longer have the
oscillations seen in the earlier iterations. The hospital inventory converges to a new level
required to meet the increased level of transfusions. This also happens with the blood bank
inventory but the maximum fluctuation is about eight units in magnitude, and it takes a while
longer to stabilise completely.
Figure 3.24b demonstrates that the number of appointments no longer has the stochastic
fluctuations seen in Figure 3.24a but converges to a new stable level after an initial fluctu-
ation of only one unit. Compare this with the peak to trough movement of about 15 units
seen previously.
Lastly, fulfilment of hospital orders no longer has the oscillatory behaviour we saw in Figure
3.25a. Instead, in Figure 3.25b we see this converges to a new stable level of supply.
Similarly, the donations, which previously fluctuated by as much as 7.5 units, converge to a
new stable level after a peak fluctuation of only a single unit.
45
(a) Inventories - Original
(b) Inventories
Figure 3.20: These two panels show the impact on both the hospital and blood bank in-
ventories when applying the blood bank correction strategy only. The top panel shows the
result before the correction, and the bottom panel shows the result after the correction.
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(a) Donor population - Original
(b) Donor Population
Figure 3.21: These two panels show the impact on the donor population when applying the
blood bank correction strategy only. The top panel shows the result before the correction
and the bottom panel shows the result after the correction.
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(a) Orders and Donations - Original
(b) Orders and Donations
Figure 3.22: These two panels show the impact on donations received by the blood bank
and order fulfilment when applying the blood bank correction strategy only. The top panel
shows the result before the correction and the bottom panel shows the result after the
correction.
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(a) Inventories - Original
(b) Inventories
Figure 3.23: These two panels show the impact on both the hospital and blood bank inven-
tories when applying both the blood bank correction strategy and the hospital correction
strategy. The top panel shows the result before the correction and the bottom panel shows
the result after the correction.
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(a) Donor population - Original
(b) Donor Population
Figure 3.24: These two panels show the impact on the donor population when applying
both the blood bank correction strategy and the hospital correction strategy. The top panel
shows the result before the correction and the bottom panel shows the result after the
correction.
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(a) Orders and Donations - Original
(b) Orders and Donations
Figure 3.25: These two panels show the impact on donations received by the blood bank
and order fulfilment when applying both the blood bank correction strategy and the hospital
correction strategy. The top panel shows the result before the correction and the bottom
panel shows the result after the correction.
51
Clearly, by changing the structure of the inventory models used by the hospital and the
blood bank it is possible to mitigate, or in some cases remove, the volatility seen in the
original model.
Figure 3.26: The impact to the blood bank inventory levels after applying both the hospital
and blood bank correction strategies under three different conditions. The first condition ap-
plies an increase to transfusions of 5%, the second applies the same increase followed by
a return to the previous level 20 days later and the last assumes that transfusion quantities
become stochastic on day 20.
Figure 3.27: The impact to hospital order quantities after applying both the hospital and
blood bank correction strategies under three different conditions. The first condition applies
an increase to transfusions of 5%, the second applies the same increase followed by a
return to the previous level 20 days later and the last assumes that transfusion quantities
become stochastic on day 20.
As a final confirmation, the response of the model to two other perturbations is tested.
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Figure 3.28: The impact to donation quantities after applying both the hospital and blood
bank correction strategies under three different conditions. The first condition applies an
increase to transfusions of 5%, the second applies the same increase followed by a return
to the previous level 20 days later and the last assumes that transfusion quantities become
stochastic on day 20.
The first test has a 5% increase in transfusions followed 20 simulation days later by an
equally sized decrease. Since this returns the transfusions to the pre-disturbance level, it
is of interest to know if the inventory in the model also returns to its pre-disturbance level.
Secondly, the model is exposed to the presence of stochastic transfusions. Transfusions
are allowed to vary uniformly over 80% to 120% of the original level. For this, we want to
know if the model exhibits the level of volatility seen previously.
The results of these tests are shown in Figures 3.26, 3.27 and 3.28. In the first section
of each panel, the case we have already tested is present: a 5% increase in the level
of transfusions. It has already been demonstrated that this converges smoothly to a new
equilibrium level. The middle section shows the effect of a 5% increase in transfusions
followed by a 5% decrease which returns the transfusions to their pre-disturbance level. In
all cases, it can be seen the variable of interest does return indeed to its pre-disturbance
level. In the case of the blood bank inventory and in the case of donations this is after a
small, transient fluctuation. Lastly, in the presence of stochastic transfusions the blood bank
inventory levels, while also stochastic, do not vary to the extent seen in the previous panels.
Most importantly, this variance is well below the level of volatility seen in the model that does
not have the corrective strategies applied. Despite transfusions varying by ±20%, none of
the quantities varied by more than ±10%. This suggests, that in addition to removing the
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volatility inherent in the unmodified system, the corrective strategies would also mitigate
the volatility present in stochastic RBC transfusions.
3.5 Concluding Remarks
It has been shown that the logistics and structure of the blood supply system can be a
source of volatility that has not previously been recognised. This volatility persists across
different parameterisations of the model. For some parameterisations, this manifests as
an oscillation, while for others it appears noisy. It is hypothesised that this is the reason
that other researchers have had trouble characterising the distribution and/or capturing an
appropriate level of volatility in their approaches.
Modifications could be made to the structure of blood inventories which are shown to miti-
gate this volatility. Further, when transfusions are allowed to be stochastic, these corrective
strategies dampen the instability engendered in hospital orders, the blood bank inventory
and in donations. The practicality of making such changes remains outside of the scope of
this thesis, yet it is the opinion of the author that these changes are not too cumbersome
to address. A reduction in the volatility of blood inventories has a concomitant effect on
the supply of blood from donors. This, in turn, leads to greater comfort in the extent to
which genuine and sustained increases in demand can be met and greater comfort that
blood inventories can weather shocks causing short-term fluctuations in demand without
engendering further volatility in the system. Reduction in volatility leads to fewer shortages
and fewer outdates.
The results presented demonstrate that the structure of the blood supply chain can cause
instability as a direct result of the goal-seeking behaviour used to manage inventories at
both hospitals and the blood bank. There are also corrective measures that can be taken to
mitigate, if not eliminate, this system-induced instability. However, even with the corrective
strategies, the system is goal-seeking the desired inventory levels, and the corrective ac-
tions give no insight about the suitability of these. It is true that a reduction in volatility would
give greater comfort to inventory managers that the system can meet real changes in de-
mand behaviour without causing additional volatility. However, since donor populations are
relatively fixed, it says nothing about the adequacy of the system to minimise shortages and
outdates. Put simply, an optimal approach should minimise both shortages and outdates
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and simply mitigating volatility does not imply that the system meets that condition. This
is because the corrective strategies do not attempt to solve for an appropriate inventory
level. While these measures respond to changes in demand quantities they do not allow
for the age of the inventory being held nor do they address the second moment of stochas-
tic demand. This is important as shortages and outdates of RBCs, occur not because of
normal demand behaviour, but because of demand behaviour that deviates from normal. A
method to determine optimal order quantities which minimise both shortages and outdates
is described in Chapter 5. To illustrate this a credible estimate of future demand is needed
and this is addressed in Chapter 4.
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Chapter 4
Modelling Demand for Blood
Chapter 5 presents a new method for optimisation of the blood supply chain. Ideally, this
new method would use projections based on actual daily transfusion data for each blood
type and hospital. While such data is available at hospitals and the blood bank, it was not
available for this research so this chapter offers a method to simulate it. Section 4.1 de-
scribes the publically available information used. These data are then used to estimate the
daily number of episodes of patient care which require a transfusion in Section 4.2. In Sec-
tion 4.3 the number of RBC units each patient needs is modelled using the Discrete Phase-
Type (DPH) distribution. It presents a new, Bayesian method for the estimation of DPH
parameters and applies it to transfusion quantities taken from available literature. Lastly, in
Section 4.4 the results from Sections 4.2 and 4.3 are brought together to model total daily
transfusion quantities for each blood type for hospitals of various types and sizes.
4.1 Available Data
The demand for blood arises out of a relatively fixed (or at least slowly changing) population.
The Australian Bureau of Statistics, in various guises, has been responsible for statistics on
Australian demography since 1905. For this research, particular interest is placed on the
population statistics for the 15 years to 2015 [8]. Over this period the Australian population
















































































Figure 4.1: The average annual Australian population over the 15 year period to 2015. Over
this time Australia has seen slow, but steady, population growth.
It is from this population that the vast majority of hospital admissions occur, the small ex-
ception being visitors to Australia. The Department of Health collects data on all of these
admissions and summary statistics are available from the Australian Institute of Health and
Welfare (AIHW) in the form of data cubes. These cubes are available over the 15 years
to 2015, and it is possible to limit the data to only those cases that had a transfusion of
RBCs. The AIHW data is captured using patient separations. A separation is recognised
once a patient leaves a hospital after an episode of care. The AIHW has full coverage of
all hospital separations in Australia, and this includes both public and private hospitals as
well as day facilities. Medicare item number (MBS) 13706 is used to identify separations
requiring a transfusion of RBCs. While there has been some change in the total number
of episodes requiring transfusions of RBCs, the quantity of separations per 1000 has not
moved too dramatically, as seen in Figure 4.2.
For convenience, it is assumed that the number of patients requiring a transfusion in each
period can be represented as independent random variables. In order to undertake the
optimisation in Chapter 5, it is desired that the distribution of daily separations is derived.
The complication faced is that these data are annual. To address this, Section4.2 uses a





















































































Figure 4.2: Hospital separations requiring a transfusion of RBCs over the 15 year period to
2015. Since this effectively controls for changes in population it shows that there is variation
in separation quantities that is not explained by changes in population.
of patients requiring a transfusion.
4.2 Modelling the Number of Patients Requiring Transfu-
sion
4.2.1 Total Separations
From the data presented in Figures 4.1 and 4.2 it is possible to obtain a naı¨ve estimate
of the number of annual separations requiring RBCs by simply taking the average of the
total number of separations. Doing this gives a figure of 187,873 annual separations. How-
ever, this does not take into account the change in population over the period. A related,
but similarly naı¨ve, approach is to estimate the average proportion of the population that
will require a blood transfusion in a single year. This can be done by summing the total
number of separations over the fifteen year observation period and dividing by the sum of
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the population over the same period. This gives an estimate of 0.886% of the population
requiring RBCs each year. However, neither of these approaches allow an appreciation
of how variable the number could be. It is true that similar approaches could be used to
estimate the variance in both the total number of separations or the proportion of the pop-
ulation requiring a transfusion of RBCs. Neither of these approaches gives a real sense of
the daily variability of the number of separations.
Patients requiring a transfusion emerge from the broader population at independent but not
identically distributed times. Further, whether there is a hospital available for them to go to
is, at this stage, irrelevant. A patient will or will not require blood regardless of there being
a hospital available to treat them. Hospital attendance is considered later in Section 4.2.2.
For now, let ⌦t (s) be the cumulative distribution function of the proportion of the population
requiring a blood transfusion at time t over the interval [t, t+ s]. To obtain the distribution of
patients requiring a transfusion Lemma 4.2.1 is needed.
Lemma 4.2.1. Let T1 < T2 < · · · < Tj < · · · < TN be independent realisations of the
times individual patients require a transfusion of RBCs from a population of size Nt. To
allow for some in the population not requiring RBCs note that Pr (Tj =1) > 0. Also note
that ⌦t (s) =
R s
0 !f (x) dx = Pr (t < Tj < t+ s). Then the number of patients arriving in
the interval (t, t+ s) has a binomial distribution with proportion parameter given by the
cumulative distribution function ⌦t (s).





1 (t < Tj  t+ s) , (4.1)
where
1 (t < Tj  t+ s) =
8>>><>>>:
1 w.p. ⌦t (s)
0 w.p. 1  ⌦t (s) .




ways of obtaining At over all possible patients. Consequently:






at [1  ⌦t (s)]Nt at . (4.2)
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Even though Lemma 4.2.1 concludes that the times that patients need blood are, on av-
erage, i.i.d., it does not require much consideration to conclude that this is not the case.
While the timing of a patient’s need for blood may be independent, it is unlikely that these
times are identically distributed. After all, some people are sicker than others so their prob-
ability of attendance would be higher than others. The factors that cause one patient to
need a transfusion would be different from the factors that cause another patient to require
a transfusion. However, the quantity ⌦t (s) can be thought of as a mixture of the under-
lying individual probabilities which gives the i.i.d. conclusion some weight. Lemma 4.2.1
uses a realistic set of assumptions. The population is finite and the rate at which patients
need blood changes depending on the interval chosen, s, and the time at which the interval
starts t. Lemma 4.2.1 is different from a common alternative view which suggests that the
process is a Poisson process. The Poisson process assumes an infinite population when
it is not. The Poisson process assumes that inter-arrival times are exponentially distributed
when there is no such constraint on the population that they should be. Lemma 4.2.1 is a
natural consequence of the assumptions made regarding the process rather than a claim
that the process fits a preconceived idea of how patients needing a transfusion should
behave.
The data give the ability to calculate 15 estimates of ⌦i (s). In this instance, the subscript
i references the beginning of the ith year and s is the period to the end of that year. A
Bayesian approach is used to generate credible estimates of ⌦i (s). Readers wishing a
comprehensive text on Bayesian Statistics are directed to Gelman et. al. [44].
The full distribution of ⌦i (s) is not observed and to get an approximation of what it might
be the problem is set up as a hierarchical Bayesian model. Accordingly, it is necessary to
choose a prior distribution for each⌦i (s). In Bayesian statistics, a prior distribution captures
any beliefs one might hold about an outcome before any evidence is taken into account.
Such a prior might be informative when something definite is known about the process
beforehand, or it might be uninformative when there is little or nothing known about the pro-
cess beforehand. Since Lemma 4.2.1 reveals the distribution of the number of patients as
binomial the use of a beta prior is useful. This is useful because the beta distribution is con-
strained to the interval [0, 1] and because it contains the uniform distribution. The property
that a posterior distribution is from the same probability distribution family as the prior distri-
bution is known as conjugacy and in such a case the prior is known as the conjugate prior
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to the likelihood function [44]. The choice of a beta prior has the additional advantage that
is it the conjugate prior to the binomial distribution. With this in mind, each ⌦i (s) has a beta
distribution and since the problem is hierarchical each shares common hyper-parameters
↵ and  . The objective is to calculate the joint distribution of ↵ and   from the data. To this
end let ⌦ = (⌦1 (s) , . . . ,⌦15 (s)), let a = (a1, . . . , a15), let n = (n1, . . . , n15) and let ⇡ (.) be
a density function. Note that the joint density of ⌦, ↵ and   is given by:


















↵+ai 1 [1  ⌦i (s)] +ni ai 1 ,
(4.3)
where   (.) is the gamma function. Using the standard hierarchical beta-binomial results
[44], the conditional posterior distribution of ⌦ is given by:
⇡ (⌦ | ↵, , a) =
15Y
i=1




  (↵+   + ni)
  (↵+ ai)  (  + ni   ai)⌦i (s)
↵+ai 1 [1  ⌦i (s)] +ni ai 1 .
(4.4)
Another application of Bayes’ law gives the posterior distribution of ↵ and   conditional on
the observed separation quantities:
⇡ (↵,  | a) = ⇡ (⌦,↵,  | a)




  (↵+  )  (↵+ ai)  (  + ni   ai)




Importantly this does not depend on ⌦ but on a credible estimate of ↵ and  , the separation
quantities represented by a and the population represented by n.
The problem is set up as a hierarchical Bayesian model as shown in Figure 4.3. The data
comprises 15 successive observations of the Australian population n and the quantity of
hospital separations requiring a transfusion of RBCs, a. These are used to estimate ⌦i (s)
for each time period i = 1 . . . , 15. As mentioned earlier beta distribution is used as a prior
as it contains the uniform distribution as a special (non-informative) case, it will restrict ⌦t
to the interval (0, 1) and has the nice property that it is a conjugate pair to the binomial
distribution. However, a difficulty arises with sampling the hyper-parameters ↵ and   as
these are on the interval (0,1). This is addressed by defining two quantities µ and ⇢ that
are transformations of ↵ and   given by the Equations (4.6) and (4.7) and are restricted the
interval (0, 1). Assuming a uniform distribution for µ and ⇢ allows a non-informative prior to














i = 1 . . . 15
Figure 4.3: A Bayesian Network describing the estimation of hyper-parameters, ↵ and  
from the observed number of patients requiring a transfusion of RBCs over 15 mutually
exclusive periods of length s.
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The hierarchical model was coded in Python, and a chain of 60,200 samples for each of
µ, ⇢, ↵ and   was generated. Limiting the trace to a length of 1,200 samples reveals the
process converges after about 50 iterations as shown in Figures 4.4 and 4.5. In order to be
safe, a burn-in of 200 iterations was used before considering autocorrelation of parameters.
While Figure 4.6 shows that µ and ⇢ exhibit significant autocorrelation, this is mitigated
somewhat in the resulting correlations of ↵ and   as shown in Figure 4.7. Autocorrelations
in an MCMC chain can be addressed by taking every kth observation rather than using
them all. This idea is called thinning, and many authors have argued against its use in
MCMC chains, suggesting that it is both unnecessary and inefficient [64] or even justifying
a ban on thinning [65].
It has been recently shown that such broad brush recommendations can be misleading
[77]. Let ⌘l be the autocorrelation associated with lag l. Suppose that each increment
of the Markov chain has a unit cost and has an additional cost of ⌫ > 0 units whenever
the quantity of interest is calculated. In this specific case, there are three quantities of
interest: ↵ and   that require calculation from the transformed hyper-parameters µ and ⇢
and, of course, the resulting density given in Equation (4.5). If the autocorrelations satisfy
⌘1   ⌘2   · · · > 0 then there is always a value of ⌫ for which thinning by taking every kth
observation will improve efficiency. Checking the autocorrelations for µ reveals that this
situation meets those criteria as a monotonic decrease in autocorrelations is present as
the lag increases. As a result, the parameter estimates will be thinned by taking every sixth
estimate, after allowing for the burn-in, to mitigate autocorrelation effects.
After applying thinning to the samples of ↵ and   it can be seen in Figure 4.8 that significant
autocorrelation has been eliminated. After allowing for burn-in and applying thinning, there
are 10,000 paired estimates of ↵ and   available.
With these results in mind, it is safe to examine the density plot of µ and ⇢ and that of ↵ and
 . These can be seen in Figure 4.9. The parameters µ and ⇢ appear uncorrelated while ↵
and   exhibit strong pairwise correlation.
It is natural to ask how well the separation quantities that were observed fit within the esti-
mations produced by this model. It can be seen in Figure 4.10 that the observed quantities
are very close to the centre of the modelled quantities for each year. Accordingly, the
parameters derived using the Bayesian network in Figure 4.3 are reasonable.
These estimates are annual. For inventory management, it is required that daily estimates
be produced. From each of the 10,000 annual estimates of ↵ and  , it is possible to com-
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Trace plot of µ







Trace plot of ⇢
Figure 4.4: The parameter trace of µ and ⇢ shows that these parameters are well mixed
within a few iterations.
pute the mean µ and variance  2 of the associated beta distribution. The annual quantity
is a sum of 365 unobserved daily quantities. Ignoring seasonality for the moment, it is pos-
sible to claim that, for a single sample, the daily mean is µ˜ = µ365 and the daily variance is
 ˜2 =  
2
3652 . Using this we can derive the parameters of the daily estimates as follows. From
the mean of the beta distribution:
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Auto correlation of µ








Auto correlation of ⇢
Figure 4.6: Autocorrelation of µ and ⇢. The autocorrelation present in µ is much greater
than that of ⇢. The dotted red line represents a 95% C.I. and is used to test for randomness.





↵˜+  ˜ + 1
⌘ . (4.9)
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Auto correlation of ↵








Auto correlation of  
Figure 4.7: Autocorrelation of ↵ and   show mild auto correlation. The dotted red line
represents a 95% C.I. and is used to test for randomness.
Substitute (4.8) into (4.9) to obtain:
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Auto correlation of ↵








Auto correlation of  
Figure 4.8: After thinning the observations, significant autocorrelation of ↵ and   has been































































































Figure 4.9: The density plots of parameters. Darker colours represent greater density.






























































Figure 4.10: Modelled separation quantities are represented by histograms. Each colour
is associated with a different year of data. The black vertical lines represent the observed
separation quantities for each year.
↵˜ (↵˜+ µ˜) =
µ˜2↵˜ (1  µ˜)
 ˜2
) ↵˜ = µ˜




Last, substitute Equation (4.12) into (4.11) to obtain:
 ˜ =
(1  µ˜)  µ˜  µ˜2    ˜2 
 ˜2
. (4.13)
With the current population of Australia being around 24,400,000 and using the parame-
ters derived in Equations (4.12) and (4.13) it is possible to estimate the daily number of
separations needing RBCs. These estimates are shown in Figure 4.11.
It is of note that the mean daily separations is 591.92 units and the standard deviation is
50.62 units. If this were a Poisson process or even if it were a binomial process with a
constant proportion parameter, one would expect the standard deviation to be close to 24
units per day, roughly half of that observed. Now that the total number of patients arriving
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Distribution of Daily Separations Requiring RBCs
Figure 4.11: Posterior predictive distribution of the number of separations requiring RBCs
each day.
at hospitals each day can be estimated, attention can be given to dividing this across all
hospitals and blood types.
4.2.2 Hospital Attendance
Australia has a mix of hospitals of varying sizes. Of these, it is estimated that 503 hospitals
are capable of performing a transfusion of RBCs. This estimate comprises 209 private hos-
pitals with operating theatres and 294 public hospitals with operating theatres and some
form of emergency department. These cover about 95% of all hospital separations and it is
assumed that this would capture very close to 100% of all separations requiring transfusion
of RBCs. While the available data does not explicitly identify hospitals the mix ranges from
large principal referral hospitals seen in capital cities and major regional centres to small
remote regional hospitals. Bed quantities range from an average of around 660 beds down
to about 40 beds. The 209 private hospitals are not reported using the same categorisation
as that used for public hospitals, so proportionality is assumed when applying that categori-
sation to them. With such a mix of large, medium and small hospitals and in the absence
of detailed data, it is believed that a reasonable approximation to actual mix of Australian
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hospitals providing transfusions can be generated.
Let a` = (a1,`, . . . , am,`) be a vector of patient quantities across m hospitals at time `. Then
a` has a multinomial distribution with proportion parameters ✓1, . . . , ✓m:








The proportion parameters ✓i can be obtained from empirical data. For this five different
hospital groups are considered. These are:
• Principal Referral. These hospitals are large and provide a comprehensive range of
services. There are 30 public hospitals in this group, and a further 21 private hospitals
have been added to this group based on a proportional split of private hospitals into
the public hospital reference groups. Examples of these hospitals would be the Royal
Melbourne Hospital which is public and the Epworth hospital which is private.
• Women’s and Children’s. Again, these are generally large hospitals however they
specialise in maternity and paediatric services. There are 12 public hospitals in this
group, and a further nine private hospitals have been added based on a proportional
split of private hospitals into the public hospital reference groups. Examples of these
hospitals would be the Royal Women’s Hospital and The Mercy Maternity hospital.
• Acute Group A. While not as large as the Principal Referral hospitals these provide a
wide range of services. There are 63 public hospitals in this group, and a further 45
private hospitals have been added based on a proportional split of private hospitals
into the public hospital reference groups.
• Acute Group B. These hospitals are smaller and provide a narrower range of special-
ist services. There were 45 public hospitals in this group, and a further 32 private
hospitals have been added based on a proportional split of private hospitals into the
public hospital reference groups.
• Acute Group C. These are the smallest hospitals considered and tend not to offer
specialist services. There are 144 public hospitals in this group, and a further 102
private hospitals have been added based on a proportional split of private hospitals
into the public hospital reference groups.
Table 4.1 shows such an estimate derived from publicly available information:
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Reference Group Number of Hospitals ✓
Principal referral 51 0.0074
Women’s and Children’s 21 0.0022
Acute group A 108 0.0033
Acute Group B 77 0.0017
Acute Group C 246 0.0004
Table 4.1: Hospital quantities and associated estimate of ✓, the proportion of separations
attending a specific hospital in the reference group.
Applying these parameter values to the multinomial distribution and using the daily separa-
tion quantities derived in Section 4.2.1 the resulting distributions of hospital attendance are
displayed in Figure 4.12.
The relative proportions of the various ABO blood types in the Australian population are
known and are given in Table 4.2.









Table 4.2: The proportion of ABO blood types in the Australian Population [15].
Using the information in Table 4.2 and another multinomial model it is possible to obtain the
distribution of patients arriving at hospitals by ABO blood type. This distribution is shown
for a selected principal referral hospital in Figure 4.13 and for a selected acute group C
hospital in Figure 4.14. It is important to observe that smaller hospitals such as those in
acute group C may not experience any patients of the rarer blood groups at all.
Attention is now given to the quantity of blood needed by each patient in the next sec-
tion.
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Figure 4.12: Hospitals of differing sizes will see different daily quantities of patients requiring
transfusion. This shows it is possible that a hospital may have no transfusions on some
days.
4.3 Modelling Transfusion Quantities
Modelling the distribution of the number of units transfused requires some discussion in
order to set up the conceptual framework. It is assumed that transfusion quantities can
be modelled using discrete phase-type distributions. In this section, some background on
the use of phase-type distributions in health care is given. A case is made for the use of
discrete phase-type distributions in modelling transfusion quantities after which the problem
is set up and solved using MCMC methods.
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Figure 4.13: Daily Separations by ABO type for a Principal Referral Hospital. Again it is
possible that no transfusion of a given blood type may occur on some days.
4.3.1 Phase-Type Distributions
Phase-type distributions are a dense class of distributions with positive support. They
are dense in the sense that any distribution with positive support can be approximated
arbitrarily well with a phase-type distribution [30]. Both continuous and discrete phase-type
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Figure 4.14: Daily Separations by ABO type for an Acute Group C Hospital. Since these
hospitals are so small it is common for no transfusions to be provided on most days.
distributions describe the time to absorption on a non-stationary Markov process. This class
of distributions was examined in detail by Neuts [74]. Readers wishing a comprehensive
coverage of these distributions are directed to his book.
One of the challenges in fitting phase-type distributions to data is that, in general, there is
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no unique representation [75]. This has usually led to fitting algorithms being restricted to
specific subclasses where a unique representation (of that subclass) can be found. How-
ever, Asmussen provided a general method for fitting continuous phase-type distributions
using expectation maximisation (EM) [6]. This approach requires reconstruction of the ini-
tial state and the sojourn times in each state for each iteration conditional on the observed
times to absorption. A modified, but discrete, version of this approach is available in a tool
called PHit designed by Callut and Dupont and is described in [25].
Bobbio and Cumani [20] give maximum likelihood estimation of acyclic continuous phase-
type distributions. Their approach relies on the computation of canonical forms described
by Cumani [31] which are shown to be unique minimal representations of continuous acyclic
phase-type distributions. Bobbio and Cumani’s approach was improved and extended to
the discrete case by Bobbio et. al. in 2003 [21].
Another common method for fitting distributions is moment matching. Johnson and Taaffe
applied this approach to mixtures of Erlang distributions, these being a special case of the
phase-type distribution [57]. Their approach was generalised to acyclic continuous and
acyclic discrete phase-type distributions of order two by Telek and Heindl [91]. It was later
extended beyond order two by Bobbio, Horva´th and Telek in [22].
Markov Chain Monte Carlo (MCMC) methods have been applied to continuous phase-type
distributions by Bladt [16]. In this approach estimation of the initial states and sojourn
times through each state are estimated using a Metropolis-Hastings algorithm while the
parameters of the phase-type distribution are estimated using Gibbs sampling. Bladt did
not consider the discrete case.
Phase-type distributions have been used in healthcare, but the range of applications so far
has been limited and these, in turn, seem to be limited to a few authors. An early example
is given by Faddy [38] where Erlang distributed clearance times were used in modelling
drug kinetics.
In several cases continuous phase-type distributions are used to model the occupancy
of geriatric beds [39, 66, 67, 96]. In the first of these, the authors point out that these
distributions exhibit attractive features for modelling length of stay and that the states can
be interpreted as corresponding to increased severity of the patient’s condition. In a similar
vein, phase-type distributions were used by Gorunescu et al. [47] for modelling hospital
bed occupancy with the objective of optimising the number of hospital beds.
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In all of these examples, continuous phase-type distributions are used. It is believed that
this is the first time discrete phase-type distributions have been used in healthcare and
indeed the first time that they have been used for modelling blood transfusions. While
MCMC methods for the estimation of continuous phase-type distributions have previously
been considered [16], it is believed that this thesis is the first where such methods have
been applied to the discrete case.
4.3.2 The Discrete Phase-type Distribution
4.3.2.1 The case for Discrete Phase-type Distributions
The quantity of RBCs required by a patient is a function of several variables: the severity
of their condition, their response to treatment, other co-morbidities and so on. In the data
available on quantities of blood transfused these factors are not visible. Even if they were,
one would expect inconsistencies in how they were recorded. Each unit of RBCs transfused
into a patient is considered a separate clinical decision. Before, during, and after each unit
is transfused, the condition of the patient is considered and only if it is warranted is a
subsequent transfusion given [94].
This motivates thinking about the transfusion process as a discrete time Markov chain
{Q (`) : `   0} on the state space S = {1, 2, . . . , n, n+ 1} where ` 2 Z+. The state n + 1
is considered an absorbing state and all other states are transient. The number of units
transfused is thus an analogue of the time to absorption, and the state space of the Markov
chain can be thought of as an analogue of different levels of severity for a patient’s condition
before each RBC unit transfused. Formally the time to absorption h is defined as:
h = inf {` : Q (`) = n+ 1} . (4.15)
Patients requiring a transfusion initially present in one of the n transient states. Let the
vector p 2 Rn+ with entries pi  1, i  n such that p01  1 represent the probability a
patient commences transfusion in any one of the n states. The probability vector of the
process at Q (0) is given by (p0, pn+1) with pn+1 = 1   p01 and Pr (Q (0) = i) = pi. After
each unit of blood is transfused, a patient transitions between states with probabilities given
in the matrix B 2 Rn⇥n+ where B = [bi,j ] and
P
j
bi,j  1. For at least one state
P
j
bi,j < 1 to
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allow the absorbing state to be reached. This allows construction of the one-step transition





where b = [bi,n+1] = (I B)1 is the n ⇥ 1 absorption probability vector. Define   (`) =




0 ` < 0,
pn+1 ` = 0,
p0
 
I B` 1 ` > 0 ,
(4.17)
and, subject to an atom, pn+1, at ` = 0, the density function   (`) is given by:
  (`) = p0B` 1b . (4.18)
This distribution is called a discrete phase-type distribution and is parametrised by p0 and
B using the notation DPH (p,B).
Consider the quantity of blood transfused, h, for a single patient. The patient presents for
transfusion in some initial state or condition. As the patient receives each unit of RBCs
their condition may improve, deteriorate or stay the same. Eventually, the patient’s con-
dition will reach an absorbing state where no further transfusions are necessary. Since a
Markov chain is used to capture the patient’s condition initially and after each transfusion,
the following definition is used:
Definition 4.3.1. Let q` be the state at time `. A sample path, s = (q0, q1, . . . , qh 1)
of length h   1 on the Markov chain {Q (`)} is the sequence of states visited prior to
absorption such that 8` 2 {0, . . . , h  1} we have 1  q`  n.
For a sample path, s, let
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ri = 1{q0=i} . (4.19)
Note that the probability of the process starting in state i can be expressed as:










Since the likelihood of s is simply the product of the initial state probability and the proba-
bility of each transition in s, it is now possible to write the likelihood of a single sample path
as:
L (p,B | s) = Pr (Q (0) = q0)
hY
`=1













Suppose observed transfusion quantities are available for a patients. Let h1, . . . , ha be the
observed transfusion quantities and let S = (s1, s2, . . . , sa) be the collection of all sample
paths for the a observations. The likelihood for the complete set of observations is:







































Unfortunately, the sample paths for each of the a patients are not observed and for a given
time to absorption, h, there are potentially a huge number of sample paths that could have
been followed. These paths are not all equally likely. In order to simulate a draw from
the set of possible sample paths that are absorbed at time h, the Markov chain must be
reversed. This begins by considering the state the process is in immediately prior to ab-
sorption xh 1 = i. The distribution of these states conditional on p andB is given by:
Pr (qh 1 = i | qh = n+ 1) =Pr (qh 1 = i) Pr (qh = n+ 1 | qh 1 = i)






where ei is a column vector with 1 as the ith element and 0 otherwise. In general for ` < h
the probability that state value of q` 1 = i precedes that of q` = j is given by:
Pr (q` 1 = i | q` = j) =Pr (q` 1 = i) Pr (q` = j | q` 1 = i)






Starting with Equation (4.24) at time h and iterating backwards using Equation (4.25) for
times ` = h   1 to ` = 1 a draw from the distribution of possible sample paths conditional
on p and B can be obtained.
In Bayesian statistics, it is often convenient to have a prior distribution that is a conju-
gate pair of the likelihood function. Equation (4.20) describes the probability density of
a multinoulli distribution. The conjugate prior of the multinoulli distribution is the Dirichlet













where ↵i > 0 are parameters of the Dirichlet distribution and   (.) is the gamma function.
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The Dirichlet distribution is also the most natural prior for a probability distribution of proba-
bilities as it ensures that the probability vector sums to one and constrains all probabilities to
the interval (0, 1). Analogous to the case with the beta distribution, a Dirichlet prior contains
the non-informative prior as a special case.
Examination of Equation (4.22) reveals that transitions from state j to any other state k are


















where  j,k > 0 are parameters of the Dirichlet distribution.






























The full posterior distribution is then proportional to:























The posterior density can be estimated using Gibbs sampling as follows:
1. Draw pi and bi,j using the prior distribution given in Equation (4.28).
2. For each patient generate a sample path, s, conditional on pi and bi,j and the ob-
served transfusion quantities using Equations (4.24) and (4.25).






yj,k,l from the simulated sample
paths.
4. Using the statistics calculated in step 3, draw pi and bi,j using the posterior distribu-
tions given in Equation (4.29).
5. Goto 2 and repeat a sufficient number of times.
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After a suitable burn-in time this process will generate credible samples from the station-












is generated. Application of the process described with an uninformative prior yields the
chart shown in Figure 4.15. Extracting an estimate of p andB from the posterior distribution











which look nothing like the original parameters used to generate the sample. This is be-
cause a DPH representation is neither unique nor, as shall be shown, minimal.
4.3.2.2 Minimal Representation
There are n2 + n   1 free parameters in a generic DPH. It would be useful if we could
approximate a distribution with a smaller number of parameters. One way of achieving this
is to use an Acyclic Discrete Phase-Type (ADPH) distribution.
Definition 4.3.2. A discrete phase type distribution (DPH) is called acyclic (ADPH) if there
exists an ordering of its states such that the matrix B is upper triangular.
Definition 4.3.2 is important for two reasons. Firstly, it can be shown that any probabil-
ity density function with positive support can be approximated arbitrarily well by an ADPH
for a sufficiently large number of states n. Since a DPH has positive support, it too can
be approximated by an ADPH with additional states [31]. Secondly, there may be bene-
fits in parameter estimation as there are
 
n2 + 3n  2  /2 free parameters for estimation
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Figure 4.15: Distribution of 1,000 observations (Black) with credible posterior estimates
(Red) using three phases.
rather than n2 + n   1. However, for some purposes, the additional states required by an
ADPH may invalidate this second reason. The rest of this chapter is solely concerned with
ADPHs.
While Equation 4.22 still holds, a small change to recognise the decrease in free parame-
ters can be made in order to state the likelihood function for an ADPH:











The change reflects the fact that once the process reaches a given state j, it can only
remain in that state or transition to a higher state.
Since the objective is to estimate an ADPH from a set of observed transfusion quantities, it
would be useful to find a representation that uses the minimum number of free parameters.
In order to do this, and analogous to the continuous time definition presented in [31], the
following definition is used:
Definition 4.3.3. For a given ADPH (p0,B), an elementary series of lengthm  n is given
by the ordered series z = (x1, x2, . . . , xm) and is the realisation of the unique states visited
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by the process prior to absorption such that 1  xi  n and xi < xi+1 8i 2 {1, 2, . . . ,m}.
Note that bxi,xi+1 > 0 and that the process will transition to the absorbing state from the xm
so, bxm,xn+1 > 0.
The ideas presented in [21] are used to compute a minimal representation of an ADPH.
Denote zj as the jth elementary series in an ADPH of order n we can see that there are a
maximum of 2n+ 1 possible elementary series. It can be seen in Figure 4.16, for example,
if an ADPH of order three is considered, there is a maximum of 7 elementary series.
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
Figure 4.16: There are 7 elementary series in the ADPH of order 3.








Theorem 4.3.1. Let Z be the set of all elementary series in an ADPH distribution and Zi
as the subset of those series that commence in state i (i,e, for which x1 = i). The Laplace








Pr (zj)  ˆ (t, zj) . (4.32)
Proof. The time spent in a given state hxi is a geometrically distributed random variable:











By application of the convolution theorem for Laplace transforms, a given time to absorption
that uses elementary series zj has the Laplace transform:






moreover, by the linearity property, the Laplace transform of the time to absorption for all




Pr (zj)  ˆ (t, zj) . (4.36)
The result follows by expressing equation 4.36 as a mixture of its initial state probabilities.
Examination of Equation (4.32) in Theorem 4.3.1 reveals that the time to absorption for an
ADPH does not depend on the order of the states. Since Equation (4.34) only depends on
the diagonal values of B it is possible to find another ADPH that is equivalent in distribu-
tion simply by changing the order of the eigenvalues of B and making adjustments to the
off-diagonal values and initial state probabilities. Let  i be an eigenvalue of B. Let B⇤ be a
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new matrix with the same eigenvalues as B but ordered such that  1    2   · · ·    n. In
order to compute B⇤ the following theorem is needed.
Theorem 4.3.2. The Laplace transform of a phase with eigenvalue  i can be represented
as the mixture of the Laplace transforms of a phase with eigenvalue  i+1 and a sequence
of two phases with eigenvalues  i and  i+1.






+ (1  w) ab
(s+ a) (s+ b)
. (4.37)




















Each elementary series can be described as a binary vector ui = [uj ], j = 1, . . . , n over
the ordered sequence of eigenvalues where uj = 1 if the eigenvalue  j is present in zi and
0 otherwise.
Definition 4.3.4. An elementary series zi of length m of an ADPH is called a basic series
if it contains the m fastest states  n m+1, . . . , n 1, n. The binary vector, u, associated
with such a series is called a basic vector and contains n m initial zeroes andm terminal
ones.
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Consider the binary vector ui = [0, 1, 0, 1, 1] on the 5-state ADPH. This is not a basic vec-
tor. However, by application of Theorem 4.3.2 it can be expressed as a mixture of two basic
series with binary vectors [0, 1, 1, 1, 1] and [0, 0, 1, 1, 1] both of which are basic vectors. Re-
peated application of Theorem 4.3.2 can be used to transform all elementary series in an
ADPH into mixtures of basic series.
Theorem 4.3.3 (Bobbio et. al. [21]). Any ADPH (p,B) has a unique minimal representation
as a mixture of basic series. This representation is known as canonical form 1 (CF1) and
takes the form ADPH (p⇤,B⇤) where:
p0⇤ =







 1 1   1 0 0 . . . 0
0  2 1   2 0 . . . 0







0 0 0 0 . . .  n
3777777777777775
. (4.40)
Proof. The proof follows as a consequence of the repeated application of Theorem 4.3.2
to an ADPH.
In order to put a generic ADPH into CF1 the following algorithm can be applied.
1. Enumerate all elementary series in ADPH (p0,B) and compute their associated
probabilities using Equation (4.31).
2. For an elementary series recursively apply Theorem 4.3.2 until it can be expressed
as a mixture of basic series.
3. Compute the weighted sum of each basic series remembering to multiply by the prob-
abilities computed in step 1.
4. Repeat steps 2 and 3 for each elementary series.
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5. Sum the weights of each of the resulting basic series to get the vector a⇤.
6. Create matrix B⇤ using the sorted eigenvalues of B as its diagonal values and com-
pute the upper off-diagonal as 1  qi



























It can easily be numerically confirmed that these are equal in distribution by choosing values
of ` and by application of Equation (4.18).
The likelihood function given in Equation (4.30) can be modified for an ADPH in canonical
form 1, to give:











4.3.3 Proof of Concept
Using the new Bayesian estimation process for DPH distributions described in Section 4.3.2
a class and a related set of methods were built using Python 3 to implement a Gibbs sam-
pler for DPH distributions. The code allows a DPH to be estimated using any of the three
forms discussed: a generic DPH, an ADPH and an ADPH in canonical form one. It makes
use of the Numpy library which exploits vectorisation that, in turn, leads to performance
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improvements. Unlike the continuous case where the estimation of benchmark distribu-
tions has been suggested [23], there are no such benchmarks for DPH estimation. So, for
testing a set of 1,000 synthetic observations were generated as the sum of two negative
binomial random variables. The part of the process which requires the most processing
time is the generation of the sample paths. In order to demonstrate the benefits of moving
to a canonical form estimate of a DPH, the following process was used:
1. Generate a random parameterisation using one of the forms with a given number of
phases.
2. Start the timer
3. Use the parameters from 1 to simulate sample paths for the synthetic data.
4. Stop the timer
5. go to 1, repeat 100 times and record the average time taken over the 100 replicates.
6. Repeat for each combination of phases 1 to 10 and parameterisation form.
Applying this process gives the chart shown in Figure 4.17. It is clear that the benefit of
using canonical form one increases with the number of phases. Further benefits can be
obtained by parallel processing of the sample paths.
A further test is to use known parameters to generate a sample of absorbing times and use
the estimation procedure to recover the known parameters. Accordingly, we use the pa-
rameters given in (4.41) to generate 1,000 observations and use Gibbs sampling to recover
estimates of these and the canonical form given in (4.42). It can be seen in Figures 4.18a
and 4.18b that both methods do a good job of recovering the underlying density.
However, the resulting estimate of the ADPH representation in equation 4.44 does not
resemble the parameters that generated it. This is because, like the DPH case, an ADPH












Figure 4.17: Average time taken to generate 1,000 sample paths using different DPH forms.
The blue line is for a generic DPH form, the green line is for a generic ADPH representation
and the red line is for an ADPH representation in canonical form one.
On the other hand the canonical form representation shown in equation 4.45 is much closer












One of the challenges with Bayesian estimation using MCMC methods is detecting whether
the MCMC chain has converged onto the target distribution. Of the alternative methods for
this, the most widely used is the Gelman-Rubin statistic. In order to calculate this statistic
at least two separate chains are needed. The value of the Gelman-Rubin statistic will con-
verge to unity if the MCMC process converges to the distribution of the target distribution.
Where a value above 1.2 is observed the MCMC chains are not considered well mixed.
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(a) Density estimation using ADPH form.
(b) Density estimation using canonical form 1
Figure 4.18: Using Gibbs sampling to estimate an ADPH and and ADPH in canonical form
results in almost identical estimates.
When we apply this statistic to the example used earlier, we find that both the ADPH case
and the canonical form case appear acceptable.
It is well known that the Gibbs process produces parameter estimates which can be prone
to serial correlation. We see precisely this in the above example. Further, it is observed that
the ADPH example tends to have more extreme autocorrelation in the parameter estimates.




Figure 4.19: Gelman-Rubin plots of DPH forms. While both forms display convergence, the
canonical form is the most stable.
form does have some parameters which are relatively uncorrelated. Autocorrelation in a
Gibbs chain can be addressed by running a longer chain and thinning it by taking every kth
sample and using these to estimate the average parameters. It was decided to undertake
this thinning for the same reasons noted in Section 4.2.1.
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(a) Autocorrelations for the ADPH form.
(b) Autocorrelations for the canonical form.
Figure 4.20: Auto correlations for selected parameters. CI have been left off for clarity. Both
forms show significant autocorrelation with those in the ADPH form being extreme.
4.3.4 An Application to Blood Transfusions
There are two papers where the data on the quantity of blood transfused into patients is
available. The first of these is by Como et. al. where transfusions for acute care patients are
considered [29]. As these patients are at the extreme end of blood transfusion quantities,
it was thought a worthwhile inclusion. Since the original data is no longer available, the
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Figure 4.21: The canonical form does have some parameters that are relatively uncorre-
lated.
values were estimated these quantities by carefully measuring the height of the bars in
their chart. This was then adjusted based on correspondence with one of the authors.
Our estimate of this data contains transfusions for 489 patients whereas the original paper
claims 479 patients had at least one unit of RBCs.
The second paper is by Banbury et. al. where postoperative infection risk after cardiovas-
cular surgery was considered [13]. Again the data had to be estimated from a chart in the
paper. In this case, however, there were a total of 7,909 patients receiving between one
and ten units of RBCs. This data were adjusted to match the total quantity claimed in the
paper.
A challenge with using these data sources and any other real-world data source is that there
is no way of determining a priori how many phases best captures the features. Accordingly,
phases from 2 to 8 were run, and judgement was used to determine the number of phases
which provided the best trade-off between fit and complexity. An alternative would be to
use AIC or cross-validation to determine the appropriate number of phases to use. Using
too many phases would be no different to using the empirical data. However, the objective
is to demonstrate that the new method of fitting a DPH using a Bayesian approach works.
Since the demonstration is a proof of concept, it does show that the approach can be used
as a framework for application to actual transfusion data should this method be applied at
a hospital or a blood bank. For the ARCBS such a data set would contain around 220,000
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individual transfusion quantities per year across all eight of the ABO blood types, two orders
of magnitude greater than the data set used by Banbury.
Figures 4.22 to 4.27 show the density of the observed data in black and the estimated
density in red. In both cases, the fit improves with the number of phases. Using 4 phases
appears to be the minimum that one might consider useful. Using 8 phases seems to fit the
Banbury et. al. data too well yet it does capture many of the salient features of the Como
et. al. data. It is suggested that a reasonable estimate for the number of phases would be
between 4 and 8.
Figure 4.22: Density estimation of data from Como et. al. using canonical form 1 and 2
Phases.
4.3.5 Closing Remarks on DPH distributions
The Bayesian method described in this section is a new method for parameter estimation
for discrete phase-type distributions. The likelihood functions for a DPH, an APDH and an
ADPH in canonical form are derived and using non-informative prior parameter estimates
are produced for each of the forms. The computation efficiency improves dramatically
when the canonical form is used. Using results based on [31] and [21] it is shown how a
DPH, which initially has n2 + n+ 1 free parameters can be reformulated as a problem with
2n  1 free parameters. This is achieved firstly by recognising an ADPH can approximate a
DPH, and then by transforming the ADPH canonical form which allows a unique minimum
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Figure 4.23: Density estimation of data from Como et. al. using canonical form 1 and 4
Phases.
Figure 4.24: Density estimation of data from Como et. al. using canonical form 1 and 8
Phases.
representation. The approach is demonstrated with an example where it was ultimately
possible to recover reasonable estimates of the parameters used to generate a synthetic
data set.
The method is applied to transfusion quantities given in two papers. While neither of these
is typical of blood transfusions, in general, it has been demonstrated that the method can
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Figure 4.25: Density estimation of data from Banbury et. al. using canonical form 1 and 2
Phases.
Figure 4.26: Density estimation of data from Banbury et. al. using canonical form 1 and 4
Phases.
provide a reasonable estimate of the densities of both. Further, while the approach is moti-
vated by blood transfusion, it could be applied to any situation where a DPH is a reasonable
choice.
Two open questions result from this. While autocorrelation within the Gibbs chains can
be addressed by thinning the chain, it may be possible to achieve a similar outcome by
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Figure 4.27: Density estimation of data from Banbury et. al. using canonical form 1 and 8
Phases.
reformulating the model as hierarchical. Under this approach, the priors would become
random variables which should converge in distribution to the latent parameter space. The
second open question is the determination of the number of phases which offers the best
trade-off between parsimony and complexity. While this second question should be simple
to address, the motivation of this section was to derive and demonstrate a new method
of parameter estimation for DPH distributions, not to provide a method to work out the
appropriate number of phases.
4.4 Putting it Together
It has been shown how, starting with annual patient separation quantities, the daily volume
of patients requiring a transfusion can be modelled as a binomial random variable where the
proportion parameter is allowed to vary. It is also demonstrated how the quantity of blood
transfused into patients can be modelled using a DPH distribution and how the parameters
of this distribution can be estimated from past transfusion quantities. For Chapter 5 it is
required that daily transfusion quantities for each hospital and blood type be available. In
order to achieve this the following process is applied:
1. Draw ↵ and   from the posterior distribution given in Equation (4.5)
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2. Convert ↵ and   into daily estimates ↵˜ and  ˜ using Equations (4.12) and (4.13).
3. Use ↵˜ and  ˜ to draw an estimate of ⌦t (s) from the beta distribution.
4. Draw the number of daily separations using Equation (4.2) and ⌦t (s)
5. Split this quantity by hospital using Equation (4.14)
6. Obtain the quantity for each blood type using the proportions in Table 4.2 again as-
suming a multinomial distribution.
7. Repeat steps 1 to 6 until sufficient patients have been generated.
8. For the each of patients computed in the previous steps use the parameters derived
in Section 4.3.4 to determine the quantity of blood each patient needs.
9. Sum these quantities by blood type, day and hospital.
Using this approach the distributions of transfusion quantities at a Principal Referral Hospi-
tal and an Acute Group C hospital are produced as shown in Figures 4.28 and 4.29.
4.5 Concluding Remarks
One of the challenges this thesis faced was that there were no transfusion data available
for use at the individual patient level. This chapter is a consequence of that lack of available
data. In order to overcome this situation, the estimation of transfusion quantities was broken
into two components.
First, the number of patients requiring a transfusion was modelled using a hierarchical
Bayesian model. While such hierarchical modelling itself is not new, the application to
patient quantities and the subsequent adjustment to daily quantities from annual quantities
is new. From there it was possible to split the patients up by ABO blood type and hospital
resulting in credible daily estimates of transfusion quantities.
The second component of transfusion quantities is the quantity of blood needed by a pa-
tient. It is claimed that the quantity of blood a patient needs is equivalent to a stopping time
on a discrete Markov process. The discrete phase-type distribution models the distribution
of such stopping times. In order to use such a distribution, it is required that the probability
vector of initial states and the probability of transition between states be known. For this
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Figure 4.28: Demand for blood at a Principal Referral hospital. A significant number of days
have no requirement to transfuse blood of a given type.
problem, they are not known. So a new method of estimating them directly from the stop-
ping times (transfusion quantities) was created. This method as tested for a generic DPH,
an ADPH and an ADPH in canonical form one and it was shown to fit synthetic and test data
in each case. This method is not limited to transfusion quantities. It can be applied when
only the stopping times are observed on a discrete time, finite state space Markov chain.
While the method was used for estimating the initial state probabilities and the transition
matrix, the use of a Gibbs sampler also allows the sample paths to be generated. Thse
sample paths could be useful to researchers in systems failure as they can be interpreted
as paths to the failure of a system.










































































An Application of Stochastic
Control
5.1 Background
A challenge that many human beings find difficult is optimal, sequential decision making
in the presence of uncertainty where the consequences are not apparent until some time
horizon has passed. Such difficulties are ably demonstrated in the “Beer Distribution Game”
[90] and in the “Blood Supply Chain Game” [60]. Fortunately, some approaches can be
used to attain or at least approximate optimality for such decisions. In Chapter 3 it was
mentioned that an optimal order quantity would address both the volatility and the level of
RBCs required. In this chapter, the problem is formulated as a Markov Decision Process
(MDP) and solved using stochastic dynamic programming (SDP). The repeated application
of this is an example of discrete time stochastic control.
In Section 5.2 the problem is set up and it is proved that it reduces to a convex optimisation.
In Section 5.3 the control problem is implemented in Python. In Section 5.4.1 the opera-
tion of the control process is discussed. The behaviour of the process demonstrated by
under different costs for shortages and outdates, for different delays between making and
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receiving an order and by varying the age of RBCs already in the inventory. In Section5.4.2
the control process is applied to the estimation of order quantities at hospitals of various
sizes and for different ABO blood types. It is compared to the current (unoptimised) or-
dering process at hospitals and is found to encourage holding less inventory and causes
less variation in order size. A consequence of having less inventory is that blood that is
transfused is fresher then under the current ordering process. In Section 5.4.4 the control
process tested for a centralised blood bank. A feature of donations is that donors frequently
do not turn up to give blood despite having an appointment to do so. The control process
is tested by allowing donors to break appointments. Later it is shown how the process can
be used to estimate how big a donor population needs to be in order to meet demand for
transfusions without generating shortages or outdates of blood.
5.1.1 Markov Decision Processes and Dynamic Programming
It is hard to introduce MDPs or dynamic programming (DP) without acknowledging the
seminal work of Bellman [14]. In his 1957 paper, the problem of decision making over a
horizon is rigorously described for the first time, and a method for solving such problems
(dynamic programming) is offered. Since then MDPs and DPs have been used in many
different applications including, but not limited to:
• LATEXuses DP to calculate hyphenations and justifications [63]
• Content aware image resizing [11]
• Power management in hybrid electric vehicles [78]
The first documented attempt at applying dynamic programming to perishable inventories
is by Van Zyl in 1963 [92]. No numerical solutions are provided in his thesis, and the as-
sumption is made that the commodity has a lifetime of two periods, but there is an extensive
mathematical examination of the problem.
Of relevance to this work is the application of MDPs in perishable inventory systems and
for healthcare systems. Blake et. al. [19] considered the problem of ordering quantities
in platelet production and showed that it was feasible to reduce costs, shortages and out-
dates. The problem addressed is the determination of an optimal production quantity that
minimises costs over some future time horizon. It was assumed that the production order
took place before observing demand and was filled without delay. The authors address the
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curse of dimensionality by binning the production of platelets into units of 5. This makes the
problem smaller but results in an approximate solution rather than an exact solution.
Haijema, van der Wal and van Dijk [51] extend the ideas in Blake et. al. by adding:
• A 1 day lead time for production
• periodicity due to different days of the week
• competing demand for “young” and “old” platelets
• alternative supply rules for the two types of demand
Again the problem is scaled down to address the curse of dimensionality, this time using a
factor of four, resulting in an approximate result. The authors also claim that the “optimal”
result is not practical for implementation and address this using tables of “order-up-to” val-
ues for each day of the week based on the predicted inventory levels. In a follow-up paper
Haijema et. al. [49] additionally examine the impact of production breaks such as Easter or
Christmas holidays. Haijema [50] addresses the optimality of issuing policies for platelets.
Interestingly this last paper demonstrates that the FIFO policy alone is not optimal in the
presence of production breaks. By adjusting the issuing policy, better timing of outdates
can reduce shortages dramatically. This is a finding that also appears in [1] although DP
was not used.
5.1.2 Stochastic Control
Stochastic control is a topic that lies within the larger field of control theory. In some sys-
tems, the response is entirely deterministic. For example, cruise control in a car will ac-
celerate the vehicle should its velocity fall below some desired level and decelerate if the
vehicle is going too fast. Stochastic control considers those systems that are subject to un-
certainty. It is easy to see how blood inventories might fall into this category of systems. The
simplest form of stochastic control summarises uncertainty into a prediction. This might be
via the use of averages or by use of a more sophisticated model such as regression. This
approach is known as model predictive control (MPC). Since MPC does not take into ac-
count all possible variation in stochastic variables the solution offered may not be optimal.
However, the advantage they offer is ease of computation and implementation.
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MPC has been applied to perishable inventory by Hedjar, Bounkel and Tadj [54]. The
control quantity used is the production rate at each time step. The authors consider the
cases where deterioration of the inventory is both known and unknown. Where it is known,
an exponential deterioration rate is used. Where it is not known, the authors use self-tuning
predictive control.
5.2 Markov Decision Process
The problem of how many RBCs to order is a Markov decision process (MDP). An MDP is
a five-tuple comprising:
• A state space
• An action space
• A state space transition probability given the action
• A reward (or cost) given the action
• A discount on future rewards (or costs)
5.2.1 The state space
The state space of this problem is captured by the inventory held at the hospital or the blood
bank. However, blood is perishable with a life of n days. Consider the inventory of a single










where Xi (`) 2 Z 0 is a random variable denoting the quantity of blood on day ` with
remaining life i. Consequently, the state space of X (.) is Zn 0.
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5.2.2 The set of Actions
The set of actions comprises all the possible orders that a hospital could make or the
quantity of blood called for by the blood bank. Blood is ordered on a daily basis to replace
inventory that has been used. However, blood that has been ordered does not turn up
immediately. There is a delay to allow for processing and transportation or, in the case of
the blood bank, to allow donors to make and attend appointments to give blood. The impact
of such delays was discussed in Chapter 3. Let U (`) be the quantity of blood ordered on
day ` noting that the blood that will actually arrive on day ` will be U (`  g) for some delay
g. Even though the quantity of blood ordered will usually be a scalar quantity the blood that









where Ui (`) 2 Z 0 denotes blood received with i days life remaining from an order placed
on day `. At the point of ordering it is assumed that the arriving blood will have t > 0
remaining days of life. This means for both hospitals and the blood bank the actual order
quantity is the scalar Ut (`), For clarity it is assumed RBCs that are ordered on day ` will
arrive in the inventory on day ` + g and will have remaining life t 2 (1, 2, . . . , n). A hospital
cannot know up front the age of the blood it will receive. It could be a mix of different ages.
However, the blood bank knows that the blood will have n less any time it takes to process
days of remaining life and all blood will be of the same age. It is assumed that after a delay
of g days there are no RBCs supplied that will outdate. That is the hospital will not receive
RBCs that have already expired.
5.2.3 State space transition probability
The quantity of RBCs available for transfusion is the sum of the opening inventory balance
plus any order received. Since it takes g days for an order to arrive:
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Y (`) = X (`) +U (`  g) (5.3)
Consequently, if one is interested in the impact of an order made at time ` this will not
manifest in the inventory in until g days have elapsed. That is: Y (`+ g) = X (`+ g) +
U (`).
On day `, patients require a total ofW (`) RBC units withW (`) 2 Z 0 and Pr (W (`)  w) =









where Vi (w) is the quantity of blood of age i that is used to satisfy demand. Since a FIFO
issuing policy is assumed note that:
Vi (w) =
8>>>><>>>>:











where the notation [a  b]+ is shorthand formax (0, a  b). It is important to recognise that in
Equation (5.5) there is a recursive relationship between successive values of Vi (w).
After satisfying demand the inventory has a closing balance ofY (`) V (W (`)) RBC units.
At the end of each day blood in the inventory is aged so,
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This allows consideration of three cases for the single step transition probabilities. The first
case occurs when the total quantity of RBCs demanded is less than or equal to the amount
of the RBCs with a single day of usable life remaining. In this case, any unused blood
is discarded. So, X (`+ 1) = A [Y (`) V (W (`))] = AY (`) whenever W (`)  Y1 (`).
The second case is when the total quantity of RBCs demanded exceeds the number of
RBCs with a single day remaining but is less than the total available for transfusion. In this
case there will be RBCs remaining in the inventory and X (`+ 1) = A [Y (`) V (W (`))].
This occurs whenever Y1 (`) < w <
nP
i=1
Yi (`). The last case is where the demand for
RBCs exceed the available units for transfusion. So, X (`+ 1) = A [Y (`) V (W (`))] = 0




X (`+ 1) =
8>>>>>>>><>>>>>>>>:
AY (`) w.p.  (Y1 (`))












Bearing this in mind, it is possible to re-write Equation (5.6) as follows:
X (`+ 1) = A [Y (`) V (W (`))]




X (`+ 2) = A [Y (`+ 1) V (W (`+ 1))]
= A [X (`+ 1) +U (`  g + 1) V (W (`+ 1))]
= A [A [X (`) +U (`  g) V (W (`))] +U (`  g + 1) V (W (`+ 1))]
= A2X (`) +
2X
i=1
Ai [U (`  g + 2  i) V (W (`+ 2  i))] .
(5.9)
It is assumed that there is a delay of g days between placing an order and receiving it so,
from these foundations, it is possible to define the g-step state transition as:
X (`+ g) = AgX (`) +
gX
i=1
Ai [U (`  i) V (W (`+ g   i))] . (5.10)
5.2.4 The cost function
For RBCs, it is required to choose an order quantity Ut (`) that minimises both the expected
quantity of shortages and the expected quantity of outdates.
Recall, from Equation (5.3) that Y (`+ g) is a function of the order quantity Ut (`) and the
inventory on handX (`+ g). Shortages resulting from an order at time ` will not be apparent
until that order is received at time ` + g. Clearly it is not optimal to order so little blood
that shortages occur on the day the order arrives. If shortages occur in the intervening
time then they cannot be associated with the order at time `, instead such a shortage is
a consequence of an earlier order. Define S (Y (`+ g)| 1) = [W (`+ g) Y (`+ g)| 1]+
as the shortages arising from inventory available at ` + g where the notation [a  b]+ is
shorthand for max (0, a  b). The expected shortage is given by:









[⌫  Y (`+ g)| 1] d (⌫)
375 , (5.11)
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where ⌫ is a realisation of W (`+ g). The recursive relationship given by Equations (5.3)
and (5.10) needs to be applied and so the expectation in Equation (5.11) is a function of
the g-fold convolution of demand.
Outdates manifest over a longer horizon. Consistent with its use in Chapter 4, let ei be
a vector of zeros with a one in the ith position. Define D (e|1Y (`+ g + t)) as the quantity
of outdates arising from the inventory available at ` + g + t that has a single day of life
remaining. Given that RBCs have a shelf life of n days, take g days to arrive in inventory
and are assumed to have t days life remaining, outdates resulting from an order on day `
will manifest in the inventory at the end of day `+ g + t. So:











[e|1Y (`+ g + t)  ⌫] d (⌫)
375 (5.12)
where ⌫ is a realisation ofW (`+ g + t). Analogous to Equation (5.11) this expectation is a
function of the g + t-fold convolution of demand.
It is now possible to define the cost function as the weighted sum of shortages and outdates
given the current inventory and orders made but not received:
G (Ut (`)) =  1S (a) +  2D (b)) (5.13)
where  1,  2 > 0 and:
a = Y (`+ g)| 1 and,
b = e|1Y (`+ g + t)
Note that a and b are random variables with dependence on past orders made but not




In some applications, it is important to recognise that future rewards or costs should be
allowed for. This typically occurs when the time value of money needs to be taken into
account in decision making. However, in this case, it is assumed that there is no discount
on future costs as the cost function is not financial.
5.2.6 The Solution
The recursive relationships in Equations (5.11) and (5.12) make exact computation quite
challenging due to the high dimensional state space of successive inventories. Nonethe-
less, the objective is to find an order quantity U⇤t (`) which minimises the weighted sum of
expected shortages and expected outdates. That is:
U⇤t (`) = argmin
Ut(`)
{E [G (Ut (`) | Y (`) ,U (`  g) , . . . ,U (`  1))]} (5.14)
Strict convexity of E [G (Ut (`) | Y (`) ,U (`  g) , . . . ,U (`  1))] means that it is possible to
find an order quantity which minimises Equation (5.13). To see this the following theorem
is required.
Theorem 5.2.1. Assume that  (⌫) > 0 and that it is right continuous.
E [G (Ut (`) | Y (`) ,U (`  g) , . . . ,U (`  1))] is a strictly convex functional of the decision
variable Ut (`) and therefore has a unique minimum.
Proof. It will be first be shown that S (a) and D (b) are both convex functions. Recall a =
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Since  (⌫) is positive, from Equation (5.16) it follows that S (a) is a strictly decreasing






























 (a+ h)  (a)
h
=  (a) .
(5.19)
Since  (a)   0 it follows that S (a) is a monotone decreasing convex function.
Recall that b = e|1Y (`+ g + t) is a realisation of the random variable whose expectation is
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For the second term let:
F (x, y) :=
Z x
b
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 (⌫) d⌫ !h!0
Z b
b


























d (⌫) =  (b) .
(5.25)





db (b) =  (b)   0 it follows that D (b) is also convex.
Now, for a given linear operator L one may write:
a = L (U (`) ,U (`  1) , . . . ,U (`  g) ,X (`))
b = L (U (`) ,U (`  1) , . . . ,U (`  g   t) ,X (`)) .
Since S (a) and D (b) are convex functions for any realisation of a and b
and by extension any realisation, u (`) ,u (`  1) , . . . ,u (`  g) , . . . ,u (`  g   t), of
U (`) ,U (`  1) , . . . ,U (`  g) , . . . ,U (`  g   t) that may be chosen, and since ut (`) is
the tth entry in the realised vector u (`) there are linear mappings H1 and H2 such that:
a = H1 (ut(l)) and b = H2 (ut (l)) .
Given this the following is a convex function of the realisations ut (`):
G (ut (`)) =  1S (H1 (ut (`))) +  2S (H2 (ut (`))) .
Consider u1t (`) and u2t (`), two realisations of Ut (`), and take   2 [0, 1]. Then, by the
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convexity of S and D almost always:
G
 






























































+ (1   )G  u2t (`)  .
Convexity of E [G (Ut (`) | Y (`) ,U (`  g) , . . . ,U (`  1))] emerges by taking the expecta-
tion, using linearity and the order preservation property.
However, knowing that an optimal order quantity, U⇤t (`), exists does not, on it’s own, provide
a solution and the combinatoric explosion associated with an exhaustive exploration of the
state space makes exact computation impossible within a reasonable period of time using
current computing.
One approach to solving this that is worth considering is to shrink the problem much as
Haijema et. al. did [51, 50]. However, the lead times experienced and the much larger
state space makes it much more challenging to do this.
A better approach is to use sample average approximation (SAA) [73, 62], an approach
to solve stochastic optimsation problems using Monte-Carlo simulation. This technique is
used to solve problems of the form:
min
x2X
{f (x) := E [F (x, ⇠)]} . (5.26)
Note the similarity of this with Equation 5.14. Specifically it is possible to generate i.i.d.
realisations of demand using  (W (.)) and use these to compute the sample average func-
tion:





G (Ut (`) | Y (`) ,U (`  g) , . . . ,U (`  1)) . (5.27)
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This allows a solution to the associated problem to be found:






This converges exponentially fast to the true solution as N !1 [62].
5.3 The Model
The mathematical framework above was implemented in a Python program. The core of
this program is the control class, and that is what will be discussed in this section. The
control class consists of three methods: computation of the objective function, optimisation
of the control variable and a method to visualise the output. The initialisation of the control
class requires the user to supply inputs for:
• the current quantity of stock held for each vintage X (`)
• the number of epochs, N , to use in determining optimal values
• a sufficiently long vector of future demand scenarios; realisations of W (.)
• the average expected age t of new inventory
• the delay between making an order and receiving it, g.
• the cost weights for shortages,  1 and outdates  2
Once the class has been initialised the user can then call the other methods. These meth-
ods are:
• objective: Computes the expected value of the observer function GˆN (Ut (`)) given a
specific order quantity and past orders made but not receivedU (`  g) , . . . ,U (`  1).
• optimise: Computes the optimal order quantity Ut (`) given the cost weights  1 and
 2.
• visualise: Creates a graph of the observer function GˆN (Ut (`)) over a given range of
order quantities, Ut (`).
The code used is shown below:
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c lass Cont ro l :
def i n i t ( s e l f , cu r r en t i n v , demand , epochs , age , delay , cs tsho r t , cs tou t ) :
s e l f . l i f e span = cu r r en t i n v . shape [ 0 ]
s e l f . age = age
s e l f . ager = np . diag ( [ 1 ] * ( s e l f . l i f e span   1) , k= 1)
s e l f . delay = delay
s e l f . hor izon = s e l f . l i f e span + delay   age
s e l f . epochs = epochs
s e l f . demand = np . random . choice (demand , s ize= s e l f . hor izon * s e l f . epochs )
s e l f . i nv = cu r r e n t i n v
s e l f . scenar ios = np . random . permutat ion ( s e l f . demand ) . reshape ( s e l f . epochs , s e l f . hor izon )
s e l f .gamma1 = cs t sho r t
s e l f .gamma2 = cs tou t
def ob j e c t i v e ( s e l f , qty , orders = [ ] ) :
shortage = np . ar ray ( [ 0 . ] * s e l f . epochs )
stock = np . t i l e ( s e l f . i nv . copy ( ) , ( s e l f . epochs , 1 ) )
b = np . ar ray ( [ 0 . ] * s e l f . epochs )
f o r i i n range ( s e l f . hor izon ) :
i f orders :
s tock [ : , s e l f . age ] += orders . pop ( )
b += s e l f . scenar ios [ : , i ]
i f i == s e l f . delay :
s tock [ : , s e l f . l i f e span   s e l f . age   1] += qty
f o r j i n range ( s e l f . l i f e span ) :
foo = b . copy ( )
b = np .maximum(0 , b   stock [ : , j ] )
s tock [ : , j ] = np .maximum(0 , s tock [ : , j ]   foo )
i f i == s e l f . delay :
shortage = b . copy ( )
i f i < s e l f . hor izon   1:
s tock = np . dot ( stock , s e l f . ager )
outdate = stock [ : , 0 ] . copy ( )
r e t u rn s e l f .gamma1 * shortage , s e l f .gamma2 * outdate






f c = 0
shr t , odte = s e l f . ob j e c t i v e ( oa , orders . copy ( ) )
i f s h r t . sum ( ) == 0:
converged = True
order = i n t ( oa )
e lse :
fa = sh r t .mean ( )   odte .mean ( )
oc = i n t (max( sh r t ) )
shr t , odte = s e l f . ob j e c t i v e ( oc , orders . copy ( ) )
f c = sh r t .mean ( )   odte .mean ( )
i f odte . sum ( ) == 0:
converged = True
order = i n t ( oc )
wh i le not converged :
ob = i n t ( round ( ( oa + oc ) / 2 , 0 ) )
shr t , odte = s e l f . ob j e c t i v e ( ob , orders . copy ( ) )
fb = sh r t .mean ( )   odte .mean ( )
i f oc   oa <= 2:
foo = [ abs ( fa ) , abs ( fb ) , abs ( f c ) ]
order = [ oa , ob , oc ] [ foo . index (min ( foo ) ) ]
converged = True
else :





f c = fb
oc = ob
re tu rn order
def v i s u a l i s e ( s e l f , lo , h i , save as=None ) :
p l o t da ta = np . ar ray ( [ l i s t ( range ( lo , h i + 1 ) ) , [ 0 ] * ( h i   l o + 1 ) ] , dtype=np . f l o a t )
f o r q ty i n p l o tda ta [ 0 ] :
shr t , odte = s e l f . ob j e c t i v e ( q ty )
p l o tda ta [ 1 ] [ p l o t da ta [ 0 ] == qty ] = sh r t .mean ( ) + odte .mean ( )
p l t . s ca t t e r ( p l o t da ta [ 0 ] , p l o t da ta [ 1 ] )
p l t . t i t l e ( ” Observer f unc t i on vs Order Quant i t y ” )
p l t . y l abe l ( ” Value o f Observer f unc t i on ” )
p l t . x l abe l ( ” Order Quant i t y ” )
p l t . x t i c k s ( np . arange ( lo , h i +1 , 1 . 0 ) , r o t a t i o n =90)
i f save as i s None :
p l t . show ( )
e lse :
p l t . save f ig ( save as + ’ . eps ’ , format= ’ eps ’ , dp i =1000)
p l t . c lose ( )
This code was tested and run on two computers separately using Jupyter Notebook. Both
an Apple iMac with a 4 GHz Intel Core i7 processor and 32Gb of memory and an Apple
MacBook Pro with a 2.8 GHz Intel core i7 processor and 16Gb of memory were used.
5.4 Results
5.4.1 Behaviour of Order Quantities
In order to appreciate what the above code does it is beneficial to start with a simple exam-
ple. Using the approach described in Chapter 4 52,000 instances of daily demand for O+
RBCs were generated for a small hospital as seen in Figure 5.1.
Suppose there is no delay between making an RBC order and receiving it from the blood
bank, that the age of RBCs when they are received is ten days, that costs associated with
shortages and outdates are  1 =  2 = 1 and that the hospital has no O+ RBCs in its
inventory. How many RBCs should the hospital order? This can be calculated to a desired
level of accuracy by choosing the number of epochs, N . In Figure 5.2a the number of
epochs chosen is small. This means that the result becomes unstable. In this case, it is
suggesting that the optimal order quantity should be three units. However, in Figure 5.2b
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Figure 5.1: Distribution of daily demand for O+ RBCs at a small hospital. On the majority
of days there is no demand for transfusion of O+ RBCs.
a larger number of epochs was chosen, resulting in a more stable solution and suggesting
that six units should be ordered.
Repeated execution of the code using fewer epochs shows how unstable the answer is with
order quantities of four, five, and nine RBCs shown in the plots in Figure 5.3. This is not
an issue when the number of epochs is sufficiently high, so from this point onwards the
number of epochs used will be set at 10,000.
The cost associated with shortages and outdates changes the shape of the observer func-
tion. The cost associated with shortages steepens the slope of the observer function on
the left-hand side of the curve while the cost associated with outdates steepens the slope
on the right-hand side. In Figure 5.4 this effect can be seen. Since both costs were equal
to each other, the optimal order quantity remains at six units irrespective of cost.
Of course, it is unlikely that both shortages and outdates would have the same costs. If the
cost of a shortage is higher than that of an outdate,  1 >  2, then larger order sizes are
encouraged. Similarly, if the cost of outdates is higher than that of shortages,  1 <  2 then
smaller order sizes are encouraged. This effect can be seen in Figure 5.5 where costs of
between 1 and 20 were applied to shortages and outdates.
As the order quantity decreases the probability that a shortage will occur increases. This
is further increased by the delay, g, between making an order and receiving it. Recall
from Equation (5.11) that the inventory on hand is a function of the g-fold convolution of
demand. As g increases there is more uncertainty associated with the available inventory
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(a) Using 10 epochs
(b) Using 10,000 epochs
Figure 5.2: The consequence of choosing different number of epochs. Higher values for
the number of epochs result in more stable estimate of the observer function.
on the day that the order will arrive, ` + g. This uncertainty arises because of the action
of Equations (5.10) and (5.3) over the delay period g. On the other hand, as the order
quantity increases the probability that a portion of that order will outdate also increases.
However, this increase is now mitigated by the delay, g. Equation (5.12) is a function of the
g + t fold convolution of demand. As g increases it is more likely that the ordered blood will
be used. Again this comes about because of the action of Equations (5.10) and (5.3) but
this time the effect takes place of the horizon g + t. The effect of order quantity and delay
on the observer function can be seen in Figure 5.6a. Since the delay g engenders more
uncertainty in future inventory levels, the optimal order quantity also increases with the size
of the delay. This can be seen in Figure 5.6b.
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Figure 5.3: Stability of the result when only 10 epochs are used. A variety of shapes are
generated, some of which do not converge on a unique solution.
Figure 5.4: As the cost of shortages and outdates increase the shape of the observer
function changes. In this case the cost of shortages and outdates are equal.
From this point forward, unless otherwise stated, the delay between making and receiving
an order at a hospital is set to 1 day. Until now the case where no RBCs are being held
in the inventory has been used. It is obvious that this is unrealistic. It will now be shown
how the age of RBCs in the inventory has an impact on the optimised order quantity. The
quantity of RBCs held in the current inventory is now set to seven units. The impact of
the remaining life of these units have on the order quantity, and the observer function is
now examined. If there is already blood in the inventory, this must be taken into account
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Figure 5.5: The optimal order quantity as it responds to different shortage and outdate
costs. Colour is provided only to make the shape of the surface clearer.
when determining an optimal order quantity. If the units in inventory are older than the
ordered RBCs, then these will be used first. However, their shorter remaining life increases
the likelihood that some, or all of them, will outdate before use. As the remaining life of
blood in the inventory increases, the likelihood it will be used increases and the likelihood
it will outdate decreases resulting in smaller order quantities. However, if the remaining life
of blood in the inventory is greater than that of blood ordered then a higher optimal order
quantity is encouraged again. The ordered blood will be used before the blood already in
the inventory and is, therefore, higher to protect against shortages. This effect is shown in
Figure 5.7a.
5.4.2 A Sequential Application
The optimisation really shows its power when applied sequentially. In this setting, it is
acting to control shortages and outdates by repeatedly determining an order quantity that
minimises the observer function based on the updated inventory and orders made but not
received. Demand data for O+ blood for a large (principal referral) hospital were generated.
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(a) The observer function changes with delay size. For longer delays
too small an order has a greater impact on shortages than that of a
shorter delay. However, a longer delay increases the likelihood that
ordered blood will be used, so too large an order has a smaller impact
on outdates than that of a shorter delay.
(b) Optimal Order Quantities change depending on the delay between
making and receiving an order.
Figure 5.6: As the size of the delay increases the additional uncertainty of demand changes
the shape of the observer function and drives an increase in the optimal order quantity.
As pointed out in Chapter 4 such a hospital would be responsible for about 0.75% of na-
tional separations. This synthetic demand data will serve as a proxy for actual demand.
Other parameters supplied are given in Table 5.1.
In order to determine the initial inventory, the average demand was multiplied by the days
on hand parameter. The result was expressed as an integer, and each RBC unit was
allocated a random age before being added to the initial inventory. The control class was
then initialised using the parameters supplied in Table 5.1 and an array of demand values
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(a) The impact of age of current inventory on optimal order quantities
(b) The impact of age of current inventory on observer function
Figure 5.7: The impact of the age of RBCs in the current inventory on order quantities and
the observer function. These charts demonstrate that the remaining life of current inventory
is important when determining how many units to order.
Parameter Value Comment
lifespan, n 42 This is the shelf life of RBCs
epochs, N 10000 The number demand scenarios to use in optimising
the order quantity
delay, g 1 The number of periods between making an order
and receiving it
average age, t 5 The expected age of new RBCs when received
cost of shortage,  1 1
cost of outdate  2 1
days on hand 10 The number of days inventory held at the beginning.
This is simply a way of initialising X (0)
Table 5.1: Unless stated otherwise, these are the parameters used in the following sections.
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different to those supplied were used as a proxy for actual demand. This ensures that the
model does not use any actual demand values in the control process. Instead, it uses
plausible “guesses” for demand quantities. The control process was then run over 1100
days of demand, the first 100 days being ignored in case there are transient effects resulting
from the starting assumptions. It can be seen in panels four and five of Figure 5.8 that the
resulting order quantities generate no shortages or outdates whatsoever.
Figure 5.8: The top panel shows the daily quantity of O+ blood demanded by patients at a
principal referral hospital. Blood used is deducted from the inventory shown in the second
panel. The blood remaining in the inventory and 10,000 plausible demand scenarios are
used to determine the order quantity shown in the third panel. Any shortages of blood or
outdates are shown in panels four and five respectively.
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For a common blood type at such a large hospital, the result is compelling. It is interesting
to observe that the order quantities in panel three match demand in panel one albeit lagged
by a single day. This is borne out by inspection of the underlying values and could lead to
the conclusion that the resulting optimisation routine converges on the (S   1, S) inventory
policy and, solves for S. In general, this is not true as shall be seen in the following cases
where demand for RBCs is low. The previous scenario was re-run, but this time the O+
blood type was replaced with AB- blood. Since this blood type is so rare, even for a large
hospital, there is little incentive to hold more than a few units in stock. Unfortunately, its
rarity also means that some shortages and outdates are unavoidable as can be seen in
Figure 5.9. Hospitals do have the advantage of being able to place emergency orders to
the blood bank should they experience shortages, and it might be better if they did not hold
any of these blood types and place an emergency order should they need it. Alternatively,
hospitals can, and do, replace demand for rare blood with transfusion of compatible blood
types. A similar observation can be made for common blood types at small hospitals as
shown in Figure 5.10. Examination of these figures does show that the optimal order quan-
tities are not lagged values of demand. The process has not converged on the (S   1, S)
inventory policy.
In some cases, it is clear that not holding any RBCs of a given type is the optimal outcome.
Consider Figure 5.11 which shows the optimal order quantities for A- RBCs at an acute
group C hospital. Demand for this blood type at such a small hospital is so low that holding
any blood at all will generate a worse outcome. So, the optimal choice is to stock none of
that type and place an emergency order with the blood bank should they need it. Alterna-
tively, it would be beneficial to pool inventory with a larger hospital or hospitals that is/are
geographically close.
An obvious question is how does the control process compare to the current ordering pro-
cess at hospitals? To test this, the current order process was set up with the same starting
inventory and the same vector of orders made but not received. The key difference is
the current order process manages hospital inventory to an issuable stock index (days on
hand), and an order is placed for the difference between the desired inventory using the
issuable stock index and the actual inventory level. The average demand over the number
of days held is used to compute the desired inventory level. In order to give the current
ordering process a reasonable chance, the days-on-hand quantity is determined by using
the optimised data suggesting a value of 5.49 for days on hand. As this needs to be an
integer value, six days was used. Overall this approach is consistent with NBA guidelines
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Figure 5.9: The daily demand for AB- blood at a principal referral hospital is shown in the
top panel. The second panel shows the blood remaining in the inventory after meeting
demand. The third panel shows the optimal order quantity. Panels four and five show
shortages and outdates respectively. For such a rare blood type even a large hospital
cannot avoid experiencing some shortages and outdates.
for managing a hospital blood inventory [71]. It does not consider orders made but not
received nor does it consider if a given order quantity increases or decreases the proba-
bility of experiencing shortages or outdates. A visual comparison of Figures 5.8 and 5.12
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Figure 5.10: The daily demand for O+ blood at a small acute hospital is given in the top
panel. The second panel shows the inventory balance after meeting demand. The optimal
order quantity is shown in panel 3 and panels four and five show shortages and outdates
respectively. It is unavoidable that a small hospital will experience shortages and outdates
even for a common blood type.
suggest that the two approaches behave quite differently. Both the inventory levels and the
order quantities seem to fluctuate more than the control process. Further, despite holding,
on average, more in the inventory, the current process still generated a shortage.
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Figure 5.11: The daily demand for A- blood for a small hospital is shown in the top panel.
The optimal strategy for such a hospital is not to hold any of this blood in inventory as shown
in the second panel. Similarly, the third panel shows that no blood of this type is ordered.
When demand does arise, it cannot be met, so all demand results in a shortage as seen in
panel 4. Since holding no inventory means no blood can outdate, the quantity in panel 5 is
always zero.
Key statistics of each approach are seen in Table 5.2. On average the optimised result
holds ten fewer RBC units in the inventory then the current process. The inventory under
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Figure 5.12: The results when applying the current ordering process used at hospitals. This
process sets the desired inventory level to 6 days stock on hand and this is recalculated
each day.
the current process is also about three times more volatile than the optimised process.
While the average order quantities using both methods are about the same, the current
process is just over twice as volatile as the optimised process. It was shown in Chapter
3 that volatility in hospital orders had a profound effect on blood bank inventories which in
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turn caused volatility in the availability of donors.
Statistic Optimised Unoptimised
Total inventory Mean 31.53 40.97
Total Inventory Standard Deviation 6.88 20.01
Order Quantity Mean 5.72 5.70
Order Quantity Standard Deviation 4.95 10.04
Table 5.2: Comparison of key statistics for the optimised process versus the current (unop-
timised) process
A consequence of having fewer RBCs in the inventory and lower volatility is that the age
of RBCs transfused is generally younger than those under the current process. While this
was not a goal of the control process, there is some evidence that fresher RBCs have fewer
complications for recipients than older RBCs [35]. This has led to consideration of reducing
the shelf life for RBCs to 21 days. However, under the current inventory policies the supply
chain may struggle to adjust to such a change [3]. The fresher RBCs transfused using the
control process described in this thesis may be a way of addressing the potential for loss of
control if the shelf life were reduced.
Figure 5.13: The ages of RBCs in the optimised case are generally younger than those in
the unoptimised case. Additionally the variation in the age of transfused RBCs is also less
than that of the unoptimised case.
5.4.3 Robustness
In this section, the robustness of the control process is tested. Of interest is how the pro-
cess responds to shocks in demand or to under or overestimation of volatility. Table 2.1 In
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Chapter 2 shows that many current researchers use the Poisson distribution for estimating
demand when testing inventory optimisation models. In Chapter 4 it was shown that the
actual demand distribution is much more complicated. In Chapters 2 and 3 it was argued
that understanding the volatility of blood inventories was key to optimising them. In this
section, the impact of assuming a Poisson process to forecast demand is analysed. Ac-
tual demand remains distributed as per the previous sections, but the demand assumption
given to the control process is replaced with a Poisson process having the same mean as
actual demand. The consequence of doing this is that the average inventory held reduces
to about half of the prior level. This can be seen in Figure 5.14. It is important to point out
here that the shortages come about because the volatility of the Poisson process is much
lower than that of actual demand. The control process still converges on a solution that
minimises shortages and outdates but this is based on the forecast volatility of the Poisson
process rather than better estimation of demand volatility. It is important that inventory man-
agers understand that underestimation of volatility can create situations where shortages
can occur. The proposed method is not a panacea for poor forecasting.
Another way to think about the robustness of the solution is to consider what happens
when demand undergoes a sudden change. This is equivalent to either having too much
inventory or not enough. In the case of too little inventory, it is more likely that a shortage
will occur until the inventory has adjusted to the new level. This adjustment takes place
in the order quantity where a large order is placed to adjust inventory levels. This can be
seen in the third panel of Figure 5.15. The speed that this happens is a direct function of
the delay between making an order and receiving it.
In the case of too much inventory then orders are suspended until the inventory level ad-
justs. This does increase the chance of experiencing an outdate, particularly if the inventory
levels are extremely overstocked. This adjustment can be seen in the third panel of Figure
5.16. Since RBCs cannot be returned to the blood bank, the speed of the adjustment is a
direct consequence of the new demand level.
5.4.4 A Centralised Blood Bank
Some changes are required to implement the approach described at a centralised blood
bank. The demand quantities at a central blood bank are not merely the sum of transfusion
quantities over all hospitals. Instead, demand at a centralised blood bank comes from
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Figure 5.14: Assuming a Poisson process for estimating future demand leads to shortages.
This is because a Poisson process, by definition, has a standard deviation equal to the
mean of the process. The use of a Poisson process for forecasting demand underesti-
mates the frequency of higher demand values thereby depleting stocks to the point where
shortages can occur.
the orders made by those hospitals. These are not just the orders they make using their
standard order process but also emergency orders placed to cover shortages. In a typical
situation, hospitals are of varying sizes these orders and shortages can vary quite a lot.
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Figure 5.15: If demand increases, the optimisation process will increase the order to adjust
to the new demand levels. This can be seen in the third panel where an order of 35 units is
placed. Afterwards the ordering behaviour is consistently between zero and 20 units.
Also, data on hospital orders were not available for this research, so these orders were
generated assuming that hospitals optimised their orders using stochastic control. In order
to mimic the order received by a central blood bank, it was assumed that the blood bank
provided RBCs to 294 hospitals. The number of each hospital type was determined using
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Figure 5.16: If demand decreases, the optimisation process will suppress orders until the
inventory adjusts to the new demand level. This may cause outdates if the reduction in
demand is large enough.
the AIHW report of Australia’s public hospitals [9]. This report gives the breakdown of
hospital types/sizes shown in Table 5.3.
To generate demand for the blood bank, the order and shortage vectors for a single hospital




Women’s and Children’s 12
Acute Group A 63
Acute Group B 45
Acute Group C 144
Total 294
Table 5.3: Assumed composition of the hospital population
quantities given in Table 5.3 so that the 294 hospitals each had their own vector of orders
and shortages, and each vector was then randomly sorted to make these unique for each
hospital. These were then summed across the hospitals to give a vector of aggregate order
quantities for each day. This gives the distribution of blood bank demand shown in Figure
5.17a. Unlike demand for transfusions at a hospital, which often has a high quantity of days
where no transfusions take place, the total demand at the blood bank has far fewer days
where no blood of a particular type is needed.
Now, the average quantity of O+ RBCs ordered is 424.00 units with a standard deviation of
35.44 units. If this were a Poisson process, the standard deviation would have been 20.60
units. Similarly, the average quantity of AB- RBCs ordered is 11.49 units with a standard
deviation of 5.81 units. Again if this were a Poisson process, the standard deviation would
have been 3.39 units. In both cases, the distribution of orders has greater dispersion than
that of a Poisson process.
At a centralised blood bank, the analogue for orders is a call for blood to be donated. One
of the features of this call for donation is that there is often a long delay between making the
call for blood and receiving it from a donor. This can be as much as 3-4 weeks, and here it
is assumed to be 21 days. This means there is a significant vector of blood that has been
called for but has not been received that needs to be taken into account when determining
the quantity of additional blood to call for. Another feature of RBCs at a centralised blood
bank is that the age of new units is known since these are newly donated. A summary
of the parameters used for optimising the call for donation at a centralised blood bank as
given in Table 5.4.
Much like the situation with hospitals optimising the call for blood using stochastic control
allows all orders to be met and results in no outdates or shortages of RBCs.
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(a) Distribution of demand for O+ RBCs
(b) Distribution of demand for AB- RBCs
Figure 5.17: Demand at a centralised blood bank is the sum of all hospital orders and
shortages for a given day.
Parameter Value Comment
lifespan, n 42 This is the shelf life of RBCs.
epochs, N 10000 The number demand scenarios to use in optimising
the order quantity.
delay, g 21 The number of periods between making an order
and receiving it.
average age t 1 The expected age of new RBCs when received.
cost of shortage,  1 1 The unit cost associated with a single shortage.
cost of outdate,  2 1 The unit cost associated with a single outdate.
days on hand 10 The number of days inventory held at the beginning.
This is used to initialise X (0).
Table 5.4: Parameters used to for a centralised blood bank.
139
Figure 5.18: The top panel shows the demand for O RBCs. This is the sum of all hospital
orders for that day. The second panel shows the quantity of O+ RBCs available in the
inventory and the third panel shows O+ RBCs used to fulfil hospital orders. The last two
panels show that after fulfilling hospital orders no shortages or outdates were experienced.
5.4.5 The Donor Population
Consideration of the donor population is important for two reasons. Firstly, donors do not
always turn up to their appointment to donate. Secondly, the population of repeat donors is
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Figure 5.19: The top panel shows the demand for AB- RBCs. This is the sum of all hospital
orders for that day. The second panel shows the quantity of O+ RBCs available in the
inventory and the third panel shows AB- RBCs used to fulfil hospital orders. The last two
panels show that after fulfilling hospital orders, even for a rare blood type, no shortages or
outdates were experienced.




In Chapters 1 and 3 it was pointed out that donors that give blood are prevented from giving
blood again for 84 days after donation. Donors transition between three states: they can be
available to give blood, they can have an appointment to give blood, or they are in lockout
having given blood in sometime in the previous 84 days. The stochastic control model
described in this chapter can be modified to allow for these features. The following logic is
applied for each day:
1. If the call for blood is more than the number of available donors then the number of
available donors is set to zero. Otherwise, the number of available donors is reduced
by the call for blood
2. Any donors at the end of their lockout period are added to the quantity of available
donors.
3. Donors in lockout have their escrow period reduced by one day.
4. Once a Donor has given blood they are moved into lockout with k days remaining.
5. The call for blood is added to the number of donors with an appointment to give blood
in d days time.
One of the features of a donor population is that appointment breaking is quite common.
In a Norwegian study, it was pointed out that between 13% and 35% of appointments to
donate do not turn up [69]. These figures have been confirmed verbally with the ARCBS.
To combat poor appointment-keeping behaviour, centralised blood banks will ask for more
donors than required, knowing that many of them will not turn up. This way they can ensure
that they get close to the required quantity of donations, yet the actual quantity that turns
up is a random variable. It is assumed that appointment breaking is a Bernoulli random
variable and donors that break their appointments are returned to the pool of available
donors. The stochastic control model was rerun this time assuming that, on average 35%
of donors will break their appointments. This means that the call for donation results in 1.54
times more donations being requested. Further, the actual quantity that will give blood is
modelled as a binomial random variable with proportion parameter 0.35.
Not surprisingly it is apparent that the uncertainty of supply causes greater volatility in
both the inventory levels and in the order quantity as shown in Figures 5.20 and 5.21.
The control process can adjust for supply uncertainty and still minimise the incidence of
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shortages and outdates. The added uncertainty also means that the average inventory
held is much higher. Tables 5.5 and 5.6 give the mean and standard deviation of inventory
held and donations needed.
Figure 5.20: Using the assumption that 35% of O+ donors will break their appointment,
an application of the optimal control process shows that the blood bank is still able to fulfil
hospital orders without generating any shortages or outdates.
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Figure 5.21: Using the assumption that 35% of AB- donors will break their appointment,
an application of the optimal control process shows that the blood bank is still able to fulfil
hospital orders without generating any shortages or outdates even for this rare blood type.
5.4.5.2 Limiting the donor population
One of the questions this research set out to answer was how big the should a donor






Total inventory Mean 636.6 1548.1
Total Inventory Standard Deviation 171.5 259.4
Donations needed Mean 424.0 425.0
Donations needed Standard Deviation 35.9 114.2





Total inventory Mean 122.5 186.9
Total Inventory Standard Deviation 31.8 53.4
Donations needed Mean 12.6 12.8
Donations needed Standard Deviation 7.2 9.6
Table 5.6: Comparison of key statistics for AB- RBCs with and without appointment break-
ing
available until the population growth slows down. If donors are not available to give blood
when called, then the required quantity is simply added to the number of donors with an
appointment. Eventually, this will grow the donor population to the point where spawning
new donors is unlikely. To test this, the O+ donor population was spawned over 10,000
simulation days. Over this period it is assumed that a new donor immediately replaces any
donors that cease. That is net donor attrition is zero. It can be seen from Figure 5.22 that
the number of donors grows quite quickly with increases to the population manifesting at
a decreasing rate. After 10,000 simulation days, and assuming that donors did not break
their appointments the size of the donor population at 10,000 days was 45,915 donors. The
process was then repeated assuming a 35% appointment break rate. Again the population
grows to a stable, but higher, 51,245. To support a 35% break rate the donor population
only needs to be 11.6% larger.
There is a small amount of slack in this population number before shortages become preva-
lent. This is because if there are not enough donors available when a call for blood is made,
there is a possibility that this can be corrected on subsequent days as additional donors
leave the lockout period. However, once the donor population falls below this lower bound,
shortages are generated regularly. If the shortfall in appointments is not able to be made up
quickly, shortages of blood will follow, and the process will never be able to stabilise.
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Figure 5.22: The donor population is allowed to grow until donors are no longer spawned.
The blue line converges on the size of the donor population needed to support the 294
hospitals assuming no appointment breaking. The orange line shows the size of the donor
population needed if, on average, 35% of donors break their appointments.
5.5 Chapter Summary
The solution proposed in this research has several features not addressed in previous
research.
Allowing a lead time for receipt of orders means that orders made but not received must
be taken into account when computing the current order quantity. As the delay between
making an order and receiving the order increases, the uncertainty of total demand over
that horizon also increases. This has the effect of encouraging larger order quantities to
allow for that uncertainty.
The age profile of the current inventory is also important. As the inventory ages, there is
a corresponding increase in the possibility of shortage due to the outdating of older stock
that expires. This causes the optimal order quantity to fall as the remaining life of inventory
increases. However, if the current inventory comprises very fresh blood already then the
risk of shortages exceeds the risk of outdate causing an increase in the optimal order
quantity under those conditions.
Other inventory approaches tend to focus on setting an optimal level of stock to hold or
determining at what point to reorder inventory. The approach described here is different.
The optimal inventory level is not explicitly calculated. Instead, the focus is on determining
how many units to order so that shortages and outdates are minimised.
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It is clear from an analysis of the results that the inventory management approach sug-
gested by the NBA, while simple, does not encourage optimal order quantities at hospitals.
Instead, it requires that higher stock levels are held and, since orders made but not re-
ceived are not taken into account it causes volatility in stock levels and orders that could be
avoided. Conversely, the approach suggested by this research would reduce the quantity
of inventory held by hospitals, reduce the volatility of both inventory levels and order quan-
tities and, as a direct consequence lead to the transfusion of fresher blood which may have
clinical benefits.
Since the size of a hospital has a role to play in the prevalence of shortages and outdates
smaller hospitals would benefit from not holding stocks of rare blood types at all. Instead,
if this blood is required, it should be ordered from the blood bank as an emergency or-
der even though such orders might be more costly. Alternatively smaller hospitals could
collaborate with larger hospitals in geographic proximity to manage their blood inventories
jointly, thereby ensuring a local supply for rarer blood types without the need for emergency
orders.
Donors breaking their appointments drive up the inventory levels and increase the volatility
of calls for blood. It also means that more donors are needed to ensure demand will be
met. Reducing the lead time attributed to a call for blood and ensuring that fewer donors
break their appointments would have a profound effect on ensuring the robustness of future
supply as it would lower inventory levels, reduce volatility and make more efficient use of
the existing donor population. Ensuring maximum donor availability is a cornerstone of
engendering the ability of the supply chain to survive exogenous shocks.
Lastly, while many of the charts in this chapter show that shortages and outdates did not
occur it is important to remember that the approach described minimises the prevalence of
these adverse outcomes, but it does not make them impossible. They could still occur, but




This thesis has examined the problem of optimal blood inventory management. Rather than
consider just hospitals or just centralised blood banks, the decision was taken to consider
the entire supply chain from donation to transfusion. This approach is at odds with much
of the research in the area which tends to focus on only one of these. Consideration of
the end-to-end supply chain is vitally important as the presence of feedback loops, and
delays at two critical points in the system induce volatility in addition to that attributable to
stochastic demand and supply.
The system dynamics model described in Chapter 3 confirmed the existence of this volatil-
ity. It was shown that the supply chain could be modified to mitigate this system induced
volatility however this would require hospitals and the blood bank to define a desired in-
ventory level for both actual inventory and orders made but not received. Removing this
volatility does make the system more robust to shocks, but it does not imply that the revised
inventory levels and/or order quantities are optimal. This approach does, in part, address
the questions of how much blood a hospital or blood bank should order. Because the re-
sult cannot be shown to be optimal and because the objective of the model was merely to
confirm the presence of additional volatility use of the model to determine order quantities
is unsatisfactory.
Optimisation of the blood supply chain requires plausible estimates of demand. For this,
the ideal data would be that from hospitals and from the blood bank itself. Unfortunately,
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this data were unavailable due to confidentiality restrictions. Perhaps paradoxically, it is
those very restrictions, and the resulting work around that forced the consideration of a
novel approach to model demand using publicly available information. Demand for blood
is doubly stochastic. Both the number of patients needing blood and the quantity of blood
each requires are random variables. Using aggregated annual quantities of patients having
a transfusion of RBCs a hierarchical Bayesian model was built to estimate daily patient
quantities given hospital size and blood type.
Modelling the transfusion quantities was more challenging. These were considered to be
an absorption time on a discrete finite state space Markov chain. In practice, however, the
state the process is not observed or, at least, not recorded. Only the transfusion quantities
themselves are available. To model the distribution of these transfusion quantities a new
method to estimate the parameters of a DPH was needed. This method also used Bayesian
analysis to obtain credible estimates of the transition probabilities. Putting the transfusion
quantities together with patient volumes allowed a plausible estimate of daily demand for
each blood type and hospital size to be created.
With the ability to generate plausible demand quantities for hospitals of any size attention
was given to how hospitals might optimise their inventory to minimise shortages and out-
dates. Using discrete-time stochastic control, the resulting solution consistently generated
order quantities that met these objectives. It was then shown that this could also be ap-
plied to a central blood bank with analogous results and, as a consequence, the minimum
number of donors required to support demand could be derived.
Importantly, while the solution provided does use blood inventories as a motivating example,
it will work for any perishable inventory with stochastic demand and stochastic supply where
the objective is to minimise waste while meeting demand.
6.1 Contribution of This Research
This research addressed four questions.
Q1: How does the supply line structure affect the level and volatility of orders, inven-
tory and the donor population?
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The presence of negative feedback loops with delays does affect the stability of the supply
chain. Since these are present in two locations within the supply chain, there is a com-
pounding effect which makes the availability of the donor population and donation quantities
quite variable. Whether this behaviour is chaotic is an open question but it does, for some
parametrisations at least, appear to be noisy. Since the model used did not have stochastic
supply or demand this volatility can only be attributed to the structure of the supply chain
itself.
It is true that modification to the supply chain could be made that would remove such system
induced volatility. However without a specific process to mitigate shortages and outdates
such a result cannot claim to be optimal.
Q2: How should the distribution of demand for blood transfusions be mod-
elled?
Demand for blood is doubly stochastic. The number of patients requiring blood is a ran-
dom variable, and the quantity of blood each patient requires is a random variable. It was
demonstrated that daily patient quantities by blood type and by hospital could be mod-
elled using publicly available information on annual separation quantities, information on
the prevalence of each blood type in the general population and information on hospital
size. A hierarchical Bayesian model was built to obtain the hyperparameters of patient vari-
ability. These were then used to obtain plausible patient admission volumes for the current
Australian population.
Modelling the transfusion quantities was more challenging. The point was made that each
unit of blood transfused was a separate clinical decision. Consequently, the argument was
put forward that the transfusion process was Markovian with an absorbing state once suf-
ficient blood had been transfused. This led to the investigation of Phase-Type distributions
since these describe stopping times on a Markov chain with an absorbing state. Data on
transfusion quantities was scarce, but two papers were found which gave some insight into
the distribution.
A new method was developed to obtain parameters of discrete phase-type distributions
when given empirical data on times to absorption. The method uses Gibbs sampling as it
iterates between sampling plausible sample paths given a transition matrix and then sam-
pling a plausible transition matrix given the samples paths. Given that it simultaneously
provides credible estimates for the initial states, the transitions and the sample paths there
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are several broad applications beyond this research. Whenever a process can be charac-
terised as a stopping time on a Markov chain, this approach is a reasonable alternative to
other methods for estimating the parameters of a DPH distribution. While it can be used
to generate point estimates of the parameter space, it also captures variability in the esti-
mation as the process converges on the credible posterior density of the parameter space.
The ability of DPH distributions to approximate any discrete distribution as well as desired
also means that the approach could be used to generate plausible samples from any dis-
crete empirical distribution. Lastly, as the approach also estimates credible sample paths,
it can be used to generate plausible state transitions. This might be useful when modelling
failure paths in reliability analysis.
Q3: What quantity of blood should be ordered to minimise the likelihood of shortages
and outdates?
Unlike other inventory models, the approach used in this research does not attempt to solve
for an optimal, fixed inventory level or an optimal reorder point. By expressing shortages
and outdates as a function of current inventory and orders made but not received, a current
order quantity can be derived numerically that minimises both shortages and outdates. It
takes into account the delay between making and receiving an order, the age of blood
in the current inventory and, in the case of a centralised blood bank, stochastic supply
resulting from donors breaking appointments. The problem was formulated as a Markov
Decision Process and the repeated, sequential application of this is an example of discrete
time stochastic control. It avoids the problems associated with a combinatoric explosion by
using sample average approximation to generate demand trajectories over the appropriate
horizon and averages over these to estimate the value of the observer function. The higher
the number of trajectories used the more accurate the solution.
Benefits of this approach are that the age of blood transfused will generally be fresher than
adherence to guidelines prepared by the NBA. Moreover, using this approach, the quantity
and variability of blood held in inventory is smaller, and the volatility of order quantities is
lower. Nonetheless, it does require inventory managers to be able to forecast both the level
and variability of future demand.
Q4: How many donors are needed to ensure demand is met?
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One sure-fire way to generate shortages of blood is not to have enough donors to meet
demand. By using the blood bank call-for-blood process to spawn donors should there be
a shortfall of available donors, it was possible to work out the smallest donor population
required to meet demand while minimising shortages and outdates. Setting the donor
population to this limit will make it extremely unlikely that any shortages will be experienced.
However successively shrinking the size of the donor population reveals that this limit is a
hard threshold. If demand exceeds the ability of a donor population to satisfy it, the process
will generate regular shortages. A donor population in excess of this provides a buffer
against shocks and changes in demand.
6.2 Opportunities for further work
Demand for blood has two cyclical components. The first is weekly with demand being
higher earlier in the week and the weekends being much lower. There is also a seasonal
effect with Christmas and Easter having lower demand than the rest of the year [32]. These
cyclical effects were not explicitly considered in this thesis, and it is possible that a better
understanding of demand cycles and incorporating them into the control process could
reduce volatility in inventory levels and order quantities still further.
The relationship between the blood bank and hospitals is shown to be important in Chapter
3 however this was not fully captured in the control process described in Chapter 5. While
orders from hospitals were used to determine the behaviour of a central blood bank the
resulting supply of those orders with the associated mix of RBC ages was not then used by
the hospital in determining its next order. Instead, the supply of RBCs to the hospital was
assumed to be of a single age. This choice was pragmatic. Since the research is, in part,
funded by the ARCBS, any proposed solution had to be accessible to inventory managers
working there. As such the decision was made that the proposed solution had to run on a
desktop computer. The solution could be modified to address this issue but the resulting
approach, if run over multiple simulation days with hundreds of simulated hospitals, would
either run extremely slowly or require access to a sizeable parallel computing system to run
in a reasonable time. Nonetheless, the resulting process would be a complete simulation
of the blood supply chain and may offer insight over and above this research.
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